| Tipo Producción |
Título |
Autor |
Año de Producción |
DOI |
Revista |
Fuente |
Cuartil de ScimagoJR o JCR* |
|
Artículo en revista científica
|
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy
|
Martín M.
|
2024
|
10.1158/1078-0432.CCR-24-0106
|
Clinical Cancer Research
|
|
2024: No disponible**, 2020: Q1
|
|
Artículo en revista científica
|
NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer
|
Taylor B.C.
|
2024
|
10.1158/2159-8290.CD-23-0519
|
Cancer Discovery
|
|
2024: No disponible**, 2020: Q1
|
|
Artículo en revista científica
|
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer
|
Wescott E.C.
|
2024
|
10.1158/2767-9764.CRC-23-0468
|
Cancer Research Communications
|
|
S/C***
|
|
Artículo en revista científica
|
Advanced Breast Cancer Guidelines in Latin America: Assessment, Adaptation, and Implementation of Fifth Advanced Breast Cancer Consensus Guidelines
|
Valencia F.
|
2024
|
10.1200/GO.22.00067
|
JCO global oncology
|
|
S/C***
|
|
Artículo en revista científica
|
Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline
|
Al Sukhun S.
|
2024
|
10.1200/GO.23.00285
|
JCO global oncology
|
|
S/C***
|
|
Artículo en revista científica
|
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology])
|
Geyer C.E.
|
2024
|
10.1200/JCO.23.01428
|
Journal of Clinical Oncology
|
|
2024: No disponible**, 2020: Q1
|
|
Artículo en revista científica
|
Survival according to the site of metastasis in triple-negative breast cancer patients: The Peruvian experience
|
Piedra-Delgado L.
|
2024
|
10.1371/JOURNAL.PONE.0293833
|
PLoS ONE
|
|
2024: No disponible**, 2020: Q1
|
|
Journal - Article
|
Subcutaneous versus intravenous administration of Trastuzumab: a minimization cost analysis with real world data from a reference cancer centre in Peru
|
Otoya, Iris | Valdiviezo, Natalia | Roque, Katia | Morante, Zaida | Vidaurre, Tatiana | Neciosup, Silvia P. | Calderon, Monica J. | Gomez, Henry L.
|
2024
|
10.3332/ECANCER.2024.1708
|
ECANCERMEDICALSCIENCE
|
|
S/C***
|
|
Review
|
Somatic Mutations in Latin American Breast Cancer Patients: A Systematic Review and Meta-Analysis
|
Martínez-Nava G.A.
|
2024
|
10.3390/DIAGNOSTICS14030287
|
Diagnostics
|
|
2024: No disponible**, 2020: Q3
|
|
Review
|
Status of breast cancer in Latin American: Results of the breast cancer revealed initiative
|
Ayala N.
|
2023
|
10.1016/J.CRITREVONC.2022.103890
|
Critical Reviews in Oncology/Hematology
|
|
Q1
|
|
Artículo en revista científica
|
Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancer
|
Nuciforo P.
|
2023
|
10.1016/J.EJCA.2022.12.020
|
European Journal of Cancer
|
|
Q1
|
|
Artículo en revista científica
|
Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer
|
Turner N.C.
|
2023
|
10.1056/NEJMOA2214131
|
New England Journal of Medicine
|
|
Q1
|
|
Artículo en revista científica
|
Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine
|
Asleh K.
|
2023
|
10.1158/1078-0432.CCR-22-2191
|
Clinical Cancer Research
|
|
Q1
|
|
Conference Paper
|
Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials
|
Pagani O.
|
2023
|
10.1200/JCO.22.01064
|
Journal of Clinical Oncology
|
|
No Aplica
|
|
Artículo en revista científica
|
End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO
|
Di Cosimo S.
|
2023
|
10.3389/FONC.2022.1028825
|
Frontiers in Oncology
|
|
Q2
|
|
Artículo en revista científica
|
Knowledge, attitudes, and behaviors toward fertility preservation in patients with breast cancer: A cross-sectional survey of physicians
|
Baek S.Y.
|
2023
|
10.3389/FONC.2023.1109694
|
Frontiers in Oncology
|
|
Q2
|
|
Artículo en revista científica
|
Subpopulation treatment effect pattern plot analysis: a prognostic model for distant recurrence-free survival to estimate delayed adjuvant chemotherapy initiation effect in triple-negative breast cancer
|
Morante Z.
|
2023
|
10.3389/FONC.2023.1193927
|
Frontiers in Oncology
|
|
Q2
|
|
Artículo en revista científica
|
Breast cancer subtype and clinical characteristics in women from Peru
|
Zavala V.A.
|
2023
|
10.3389/FONC.2023.938042
|
Frontiers in Oncology
|
|
Q2
|
|
Review
|
Severe cardiac events induced by combination immunotherapy in patients with cancer: a meta-analysis
|
Valenzuela-Rodriguez G.
|
2023
|
10.5114/AOMS/168124
|
Archives of Medical Science
|
|
Q2
|
|
Review
|
Sex, immunity, and cancer
|
Pinto J.A.
|
2022
|
10.1016/J.BBCAN.2021.188647
|
Biochimica et Biophysica Acta - Reviews on Cancer
|
|
Q1
|
|
Review
|
Streamlining breast cancer and colorectal cancer biosimilar regulations to improve treatment access in Latin America: an expert panel perspective
|
Teran E.
|
2022
|
10.1016/S1470-2045(22)00121-8
|
Lancet Oncology, The
|
|
Q1
|
|
Artículo en revista científica
|
Association between Ancestry-Specific 6q25 Variants and Breast Cancer Subtypes in Peruvian Women
|
Zavala V.A.
|
2022
|
10.1158/1055-9965.EPI-22-0069
|
Cancer Epidemiology Biomarkers and Prevention
|
|
Q1
|
|
Artículo en revista científica
|
Oncological Care During First Peruvian National Emergency COVID-19 Pandemic: A Multicentric Descriptive Study
|
Valdiviezo N.
|
2022
|
10.2147/CMAR.S350038
|
Cancer Management and Research
|
|
Q2
|
|
Artículo en revista científica
|
The impact of telemedicine on cancer care: real-world experience from a Peruvian institute during the COVID-19 pandemic
|
Roque K.
|
2022
|
10.2217/FON-2022-0239
|
Future Oncology
|
|
Q1
|
|
Artículo en revista científica
|
Association between PIK3CA Mutations in Blood and Tumor-Infiltrating Lymphocytes in Peruvian Breast Cancer Patients
|
Castaneda C.A.
|
2022
|
10.31557/APJCP.2022.23.10.3331
|
Asian Pacific Journal of Cancer Prevention
|
|
Q3
|
|
Artículo en revista científica
|
Human Papillomavirus, Cytomegalovirus Infection and P16 Staining in Breast Tumors from Peruvian Women
|
Calderon G.
|
2022
|
10.31557/APJCP.2022.23.5.1571
|
Asian Pacific Journal of Cancer Prevention
|
|
Q3
|
|
Artículo en revista científica
|
Comparative Profiling of Circulating Exosomal Small RNAs Derived From Peruvian Patients With Tuberculosis and Pulmonary Adenocarcinoma
|
Guio H.
|
2022
|
10.3389/FCIMB.2022.909837
|
Frontiers in Cellular and Infection Microbiology
|
|
Q1
|
|
Artículo en revista científica
|
Prognostic Capability of TNBC 3-Gene Score among Triple-Negative Breast Cancer Subtypes
|
Araujo J.M.
|
2022
|
10.3390/CANCERS14174286
|
Cancers
|
|
Q1
|
|
Artículo en revista científica
|
Neoadjuvant pertuzumab in non-metastatic HER2-positive breast tumors: Multicentric study in Peru (NeoHer)
|
Falcon S.
|
2022
|
10.3892/MCO.2022.2503
|
Molecular and Clinical Oncology
|
|
Q3
|
|
Journal - Review
|
Immunotherapy in triple-negative breast cancer: A literature review and new advances
|
Valencia, Guillermo Arturo | Rioja, Patricia | Morante, Zaida | Ruiz, Rossana | Fuentes, Hugo | Castaneda, Carlos A. | Vidaurre, Tatiana | Neciosup, Silvia | Gomez, Henry L.
|
2022
|
10.5306/WJCO.V13.I3.219
|
World Journal of Clinical Oncology
|
|
S/C***
|
|
Artículo en revista científica
|
Impact of the Delayed Initiation of Adjuvant Chemotherapy in the Outcome of Triple Negative Breast Cancer
|
Morante Z.
|
2021
|
10.1016/J.CLBC.2020.09.008
|
Clinical Breast Cancer
|
|
Q2
|
|
Artículo en revista científica
|
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial
|
Albain K.S.
|
2021
|
10.1093/JNCI/DJAA148
|
Journal of the National Cancer Institute
|
|
Q1
|
|
Artículo en revista científica
|
Tumor-specific major histocompatibility-II expression predicts benefit to anti⇓PD-1/L1 therapy in patients with HER2-negative primary breast cancer
|
Gonzalez-Ericsson P.I.
|
2021
|
10.1158/1078-0432.CCR-21-0607
|
Clinical Cancer Research
|
|
Q1
|
|
Artículo en revista científica
|
Copy number aberration analysis to predict response to neoadjuvant antiHER2 therapy: results from the NeoALTTO phase III clinical trial
|
Venet D.
|
2021
|
10.1158/1078-0432.CCR-21-1317
|
Clinical Cancer Research
|
|
Q1
|
|
Artículo en revista científica
|
Alpha-smooth muscle actin expression in the stroma predicts resistance to Trastuzumab in patients with Early-stage HER2-positive breast cancer
|
Vathiotis I.A.
|
2021
|
10.1158/1078-0432.CCR-21-2103
|
Clinical Cancer Research
|
|
Q1
|
|
Review
|
Practice-changing use of the 21-Gene test for the management of patients with early-stage breast cancer in Latin America
|
Gomez H.L.
|
2021
|
10.1200/GO.21.00008
|
JCO Global Oncology
|
|
Q1
|
|
Review
|
Axillary management in early breast cancer with onset surgical management and positive sentinel lymph node
|
Vasquez L.P.R.
|
2021
|
10.3332/ECANCER.2021.1193
|
ecancermedicalscience
|
|
Q3
|
|
Artículo en revista científica
|
The current situation regarding the availability and accessibility of anticancer drugs for breast cancer in the Peruvian public health systems
|
Valencia-Mesías G.
|
2021
|
10.3332/ECANCER.2021.1224
|
ecancermedicalscience
|
|
Q3
|
|
Journal - Article
|
A biomarker study in Peruvian males with breast cancer
|
Castaneda, Carlos A. | Castillo, Miluska | Bernabe, Luis A. | Sanchez, Joselyn | Torres, Ebert | Suarez, Nancy | Tello, Katherine | Fuentes, Hugo | Dunstan, Jorge | De la Cruz, Miguel | Cotrina, Jose Manuel | Abugattas, Julio | Guerra, Henry | Gomez, Henry L.
|
2021
|
10.5306/WJCO.V12.I10.926
|
World Journal of Clinical Oncology
|
|
S/C***
|
|
Journal - Review
|
Adaptation of international coronavirus disease 2019 and breast cancer guidelines to local context
|
Valencia, Guillermo Arturo | Neciosup, Silvia | Gomez, Henry L. | Benites, Maria Del Pilar | Falcon, Silvia | Moron, David | Veliz, Karin | Maldonado, Mike | Auqui, Rodrigo
|
2021
|
10.5306/WJCO.V12.I1.31
|
World Journal of Clinical Oncology
|
|
S/C***
|
|
Journal - Article
|
PIK3CA mutation in non-metastatic triple-negative breast cancer as a potential biomarker of early relapse: A case report
|
Valencia, Guillermo Arturo | Rioja, Patricia | Morante, Zaida | Araujo, Jhajaira M. | Vallejos, Heberth Daniel | Guerra, Henry | Gomez, Henry L.
|
2021
|
10.5306/WJCO.V12.I8.702
|
World Journal of Clinical Oncology
|
|
S/C***
|
|
Artículo en revista científica
|
Cancer research in Latin America, 2014-2019, and its disease burden
|
Lewison G.
|
2021
|
10.5530/JSCIRES.10.1S.19
|
Journal of Scientometric Research
|
|
Q3
|
|
Artículo en revista científica
|
Clinical Outcomes in Early Breast Cancer with a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial
|
Sparano J.A.
|
2020
|
10.1001/JAMAONCOL.2019.4794
|
JAMA Oncology
|
|
Q1
|
|
Review
|
Multigene assays in early breast cancer: Insights from recent phase 3 studies
|
Markopoulos C.
|
2020
|
10.1016/J.EJSO.2019.10.019
|
European Journal of Surgical Oncology
|
|
Q1
|
|
Artículo en revista científica
|
Scientific publications in cancer: in Latin America, strong scientific networks increase productivity (the TENJIN study)
|
Ruiz-Patiño A.
|
2020
|
10.1016/J.JCLINEPI.2020.05.033
|
Journal of Clinical Epidemiology
|
|
Q1
|
|
Editorial
|
Lung Cancer in Peru
|
Ruiz R.
|
2020
|
10.1016/J.JTHO.2020.01.018
|
Journal of Thoracic Oncology
|
|
No Aplica
|
|
Erratum
|
Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial (British Journal of Cancer, (2019), 120, 10, (959-967), 10.1038/s4141
|
Ribi K.
|
2020
|
10.1038/s41416-019-0709-x
|
British Journal of Cancer
|
|
No Aplica
|
|
Artículo en revista científica
|
Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial
|
Eiger D.
|
2020
|
10.1038/S41416-020-0786-X
|
British Journal of Cancer
|
|
Q1
|
|
Artículo en revista científica
|
Lymph node ratio as best prognostic factor in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy
|
De la Cruz-Ku G.A.
|
2020
|
10.1111/TBJ.13988
|
Breast Journal
|
|
Q2
|
|
Artículo en revista científica
|
Human epidermal growth factor receptor 2–positive breast cancer is associated with Indigenous American ancestry in Latin American women
|
Marker K.M.
|
2020
|
10.1158/0008-5472.CAN-19-3659
|
Cancer Research
|
|
Q1
|
|
Artículo en revista científica
|
ABC4 Consensus: First Latin American Meeting—Assessment, Comments, and Application of Its Recommendations
|
Gomez H.L.
|
2020
|
10.1200/GO.20.00081
|
JCO Global Oncology
|
|
S/C***
|
|
Artículo en revista científica
|
Absolute improvements in freedom from distant recurrence to tailor adjuvant endocrine therapies for premenopausal women: Results from TExT and Soft
|
Pagani O.
|
2020
|
10.1200/JCO.18.01967
|
Journal of Clinical Oncology
|
|
Q1
|
|
Conference Paper
|
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11-CIBOMA/2004-01)
|
Lluch A.
|
2020
|
10.1200/JCO.19.00904
|
Journal of Clinical Oncology
|
|
No Aplica
|
|
Review
|
Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience
|
De-La-Cruz-Ku G.
|
2020
|
10.1371/JOURNAL.PONE.0237811
|
PLoS ONE
|
|
Q1
|
|
Artículo en revista científica
|
Neutrophil-to-lymphocyte ratio predicts early mortality in females with metastatic triple-negative breast cancer
|
de la Cruz-Ku G.
|
2020
|
10.1371/JOURNAL.PONE.0243447
|
PLoS ONE
|
|
Q1
|
|
Artículo en revista científica
|
Diagnosis and treatment of HER2 + breast cancer: Clinical Practice Guide of the Peruvian Society of Cancerology
|
Morante Z.D.
|
2020
|
10.15381/ANALES.V81I4.18839
|
|
|
S/C***
|
|
Artículo en revista científica
|
Covid-19 in cancer patients: A systematic review
|
Castañeda C.A.
|
2020
|
10.17843/RPMESP.2020.374.5976
|
Revista Peruana de Medicina de Experimental y Salud Publica
|
|
Q3
|
|
Artículo en revista científica
|
Breast-conserving surgery vs. total mastectomy in patients with triple negative breast cancer in early stages: A propensity score analysis
|
De-La-Cruz-Ku G.
|
2020
|
10.3233/BD-190391
|
Breast Disease
|
|
Q4
|
|
Artículo en revista científica
|
Relationship between tumor-associated immune infiltrate and p16 staining over clinicopathological features in acral lentiginous melanoma
|
Castaneda C.A.
|
2019
|
10.1007/S12094-019-02033-X
|
Clinical and Translational Oncology
|
|
Q2
|
|
Artículo en revista científica
|
Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial
|
Ribi K.
|
2019
|
10.1038/S41416-019-0435-4
|
British Journal of Cancer
|
|
Q1
|
|
Artículo en revista científica
|
Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer
|
Sparano J.A.
|
2019
|
10.1056/NEJMOA1904819
|
New England Journal of Medicine
|
|
Q1
|
|
Artículo en revista científica
|
Final analysis of the prevention of early menopause study (POEMS)/SWOG intergroup S0230
|
Moore H.C.F.
|
2019
|
10.1093/JNCI/DJY185
|
Journal of the National Cancer Institute
|
|
Q1
|
|
Note
|
Role of undifferentiation markers and androgen receptor expression in triple-negative breast cancer
|
Castaneda C.A.
|
2019
|
10.1111/tbj.13464
|
Breast Journal
|
|
No Aplica
|
|
Journal - Editorial Material
|
Role of undifferentiation markers and androgen receptor expression in triple-negative breast cancer
|
Castaneda, Carlos A. | Castillo, Miluska | Enciso, Javier A. | Enciso, Nathaly | Bernabe, Luis A. | Sanchez, Joselyn | Guerra, Henry | Chavez, Carlos | Landa-Baella, Maria | De-La-Cruz, Miguel | Villa-Robles, Maria | Tello, Katherine | Gomez, Henry L.
|
2019
|
10.1111/TBJ.13464
|
Breast Journal
|
|
Q3
|
|
Review
|
Erratum : Triple-negative breast cancers with amplication of JAK2 at the 9p24 locus demonstrate JAK2-specic dependence (Science Translational Medicine (2019) 11, 476, (eaaw6162), 10.1126/scitranslmed.aaw6162)
|
Balko J.M.
|
2019
|
10.1126/scitranslmed.aaw6162
|
Science Translational Medicine
|
|
Q1
|
|
Erratum
|
Correction: RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: Therapeutic cooperation between MEK and PD-1/PD-L1 immune checkpoint inhibitors(Clin Cancer Res. (2016)22:6 (1499-509) DOI: 10
|
Loi S.
|
2019
|
10.1158/1078-0432.CCR-18-4264
|
Clinical Cancer Research
|
|
No Aplica
|
|
Artículo en revista científica
|
Breast cancer PAM50 signature: Correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series
|
Picornell A.C.
|
2019
|
10.1186/S12864-019-5849-0
|
BMC Genomics
|
|
Q1
|
|
Artículo en revista científica
|
Level of tumor-infiltrating lymphocytes and density of infiltrating immune cells in different malignancies
|
Castaneda C.A.
|
2019
|
10.2217/BMM-2019-0178
|
Biomarkers in Medicine
|
|
Q2
|
|
Artículo en revista científica
|
Tumor protein p53 and K-ras gene mutations in Peruvian patients with gallbladder cancer
|
Vidaurre T.
|
2019
|
10.31557/APJCP.2019.20.1.289
|
Asian Pacific Journal of Cancer Prevention
|
|
Q2
|
|
Review
|
Precision medicine for locally advanced breast cancer: Frontiers and challenges in Latin America
|
Pinto J.A.
|
2019
|
10.3332/ECANCER.2019.896
|
ecancermedicalscience
|
|
Q3
|
|
Review
|
Critical review of axillary recurrence in early breast cancer
|
Castaneda C.
|
2018
|
10.1016/J.CRITREVONC.2018.06.013
|
Critical Reviews in Oncology/Hematology
|
|
Q1
|
|
Artículo en revista científica
|
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial
|
Colleoni M.
|
2018
|
10.1016/S1470-2045(17)30715-5
|
Lancet Oncology, The
|
|
Q1
|
|
Artículo en revista científica
|
Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer
|
Araujo J.M.
|
2018
|
10.1038/S41598-018-23099-7
|
Scientific Reports
|
|
Q1
|
|
Artículo en revista científica
|
Tailoring adjuvant endocrine therapy for premenopausal breast cancer
|
Francis P.A.
|
2018
|
10.1056/NEJMOA1803164
|
New England Journal of Medicine
|
|
Q1
|
|
Artículo en revista científica
|
Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer
|
Sparano J.A.
|
2018
|
10.1056/NEJMOA1804710
|
New England Journal of Medicine
|
|
Q1
|
|
Artículo en revista científica
|
Gender and outcomes in non-small cell lung cancer: An old prognostic variable comes back for targeted therapy and immunotherapy?
|
Pinto J.A.
|
2018
|
10.1136/ESMOOPEN-2018-000344
|
ESMO Open
|
|
2018: No disponible**, 2020: Q1
|
|
Artículo en revista científica
|
Pathological response in a triple-negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann's refined classification
|
Echavarria I.
|
2018
|
10.1158/1078-0432.CCR-17-1912
|
Clinical Cancer Research
|
|
Q1
|
|
Artículo en revista científica
|
Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel
|
Sharma P.
|
2018
|
10.1158/1078-0432.CCR-18-0585
|
Clinical Cancer Research
|
|
Q1
|
|
Artículo en revista científica
|
Expressed gene fusions as frequent drivers of poor outcomes in hormone receptor–positive breast cancer
|
Matissek K.J.
|
2018
|
10.1158/2159-8290.CD-17-0535
|
Cancer Discovery
|
|
Q1
|
|
Artículo en revista científica
|
Implementation of computerized physician order entry for chemotherapy: A Latin American experience
|
Valencia F.S.
|
2018
|
10.1200/CCI.18.00041
|
JCO clinical cancer informatics
|
|
2018: No disponible**, 2020: Q1
|
|
Artículo en revista científica
|
Breast cancer subtype and survival among Indigenous American women in Peru
|
Tamayo L.I.
|
2018
|
10.1371/JOURNAL.PONE.0201287
|
PLoS ONE
|
|
Q1
|
|
Artículo en revista científica
|
Clinicopathological predictors of long-term benefit in breast cancer treated with neoadjuvant chemotherapy
|
Galvez M.
|
2018
|
10.5306/wjco.v9.i2.33
|
World Journal of Clinical Oncology (discontinued)
|
|
Q2
|
|
Journal - Article
|
Clinicopathological predictors of long-term benefit in breast cancer treated with neoadjuvant chemotherapy
|
Galvez, Marco | Castaneda, Carlos A. | Sanchez, Joselyn | Castillo, Miluska | Pamela Rebaza, Lia | Calderon, Gabriela | De La Cruz, Miguel | Manuel Cotrina, Jose | Abugattas, Julio | Dunstan, Jorge | Guerra, Henry | Mejia, Omar | Gomez, Henry L.
|
2018
|
10.5306/WJCO.V9.I2.33
|
|
|
S/C***
|
|
Artículo en revista científica
|
RNA sequencing to predict response to neoadjuvant anti-HER2 therapy a secondary analysis of the NeoALTTO randomized clinical trial
|
Fumagalli D.
|
2017
|
10.1001/jamaoncol.2016.3824
|
JAMA Oncology
|
|
Q1
|
|
Journal-article
|
RNA sequencing to predict response to neoadjuvant anti-HER2 therapy a secondary analysis of the NeoALTTO randomized clinical trial
|
|
2017
|
10.1001/JAMAONCOL.2016.3824
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy A Secondary Analysis of the NeoALTTO Randomized Clinical Trial
|
Fumagalli, Debora | Venet, David | Ignatiadis, Michail | Azim, Hatem A., Jr. | Maetens, Marion | Rothe, Francoise | Salgado, Roberto | Bradbury, Ian | Pusztai, Lajos | Harbeck, Nadia | Gomez, Henry | Chang, Tsai-Wang | Coccia-Portugal, Maria Antonia | Di Cosimo, Serena | de Azambuja, Evandro | de la Pena, Lorena | Nuciforo, Paolo | Brase, Jan C. | Huober, Jens | Baselga, Jose | Piccart, Martine | Loi, Sherene | Sotiriou, Christos
|
2017
|
10.1001/JAMAONCOL.2016.3824
|
JAMA Oncology
|
|
Q1
|
|
Review
|
Selecting postoperative adjuvant systemic therapy for early stage breast cancer: A critical assessment of commercially available gene expression assays
|
Hyams D.M.
|
2017
|
10.1002/jso.24561
|
Journal of Surgical Oncology
|
|
Q1
|
|
Journal-article
|
Selecting postoperative adjuvant systemic therapy for early stage breast cancer: A critical assessment of commercially available gene expression assays
|
|
2017
|
10.1002/JSO.24561
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Review
|
Selecting postoperative adjuvant systemic therapy for early stage breast cancer: A critical assessment of commercially available gene expression assays
|
Hyams, David M. | Schuur, Eric | Angel Aristizabal, Javier | Bargallo Rocha, Juan Enrique | Cabello, Cesar | Elizalde, Roberto | Garcia-Estevez, Laura | Gomez, Henry L. | Katz, Artur | Nunez De Pierro, Anibal
|
2017
|
10.1002/JSO.24561
|
JOURNAL OF SURGICAL ONCOLOGY
|
|
Q1
|
|
Artículo en revista científica
|
Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer
|
Buleje J.
|
2017
|
10.1002/MGG3.301
|
Molecular genetics & genomic medicine
|
|
2017: No disponible**, 2020: Q3
|
|
Erratum
|
Erratum to: Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial (Breast Cancer Research and Treatment, (2016), 156,
|
González-Rivera M.
|
2017
|
10.1007/s10549-017-4396-0
|
Breast Cancer Research and Treatment
|
|
No Aplica
|
|
Artículo en revista científica
|
Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America
|
Castaneda C.A.
|
2017
|
10.1007/S12094-017-1685-3
|
Clinical and Translational Oncology
|
|
Q2
|
|
Artículo en revista científica
|
RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer
|
Baselga J.
|
2017
|
10.1016/J.CLBC.2017.05.006
|
Clinical Breast Cancer
|
|
Q2
|
|
Artículo en revista científica
|
MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation
|
Lee K.m.
|
2017
|
10.1016/J.CMET.2017.09.009
|
Cell Metabolism
|
|
Q1
|
|
Artículo en revista científica
|
Exploring disparities in incidence and mortality rates of breast and gynecologic cancers according to the Human Development Index in the Pan-American region
|
Martínez-Mesa J.
|
2017
|
10.1016/j.puhe.2017.04.017
|
Public Health
|
|
Q2
|
|
Journal-article
|
Exploring disparities in incidence and mortality rates of breast and gynecologic cancers according to the Human Development Index in the Pan-American region
|
|
2017
|
10.1016/J.PUHE.2017.04.017
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
Exploring disparities in incidence and mortality rates of breast and gynecologic cancers according to the Human Development Index in the Pan-American region
|
Martinez-Mesa, J. | Werutsky, G. | Michiels, S. | Pereira Filho, C. A. S. | Duenas-Gonzalez, A. | Zarba, J. J. | Mano, M. | Villarreal-Garza, C. | Gomez, H. | Barrios, C. H.
|
2017
|
10.1016/J.PUHE.2017.04.017
|
PUBLIC HEALTH
|
|
Q3
|
|
Review
|
The implementation of the Plan Esperanza and response to the imPACT Review
|
Vidaurre T.
|
2017
|
10.1016/S1470-2045(17)30598-3
|
Lancet Oncology, The
|
|
Q1
|
|
Journal - Article
|
<i>In silico</i> evaluation of DNA Damage Inducible Transcript 4 gene (<i>DDIT4</i>) as prognostic biomarker in several malignancies
|
Pinto, Joseph A. | Rolfo, Christian | Raez, Luis E. | Prado, Alexandra | Araujo, Jhajaira M. | Bravo, Leny | Fajardo, Williams | Morante, Zaida D. | Aguilar, Alfredo | Neciosup, Silvia P. | Mas, Luis A. | Bretel, Denisse | Balko, Justin M. | Gomez, Henry L.
|
2017
|
10.1038/S41598-017-01207-3
|
Scientific Reports
|
|
Q1
|
|
Journal-article
|
In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies
|
|
2017
|
10.1038/S41598-017-01207-3
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies
|
Pinto J.
|
2017
|
10.1038/S41598-017-01207-3
|
Scientific Reports
|
|
Q1
|
|
Artículo en revista científica
|
Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: An exploratory analysis of TEXT and SOFT
|
Regan M.M.
|
2017
|
10.1093/ANNONC/MDX285
|
Annals of Oncology
|
|
Q1
|
|
Artículo en revista científica
|
Cohort profile: The Mexican American Mano a Mano Cohort
|
Chow W.H.
|
2017
|
10.1093/IJE/DYV016
|
International Journal of Epidemiology
|
|
Q1
|
|
Artículo en revista científica
|
Genomic profiling of ER+ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance
|
Giltnane J.M.
|
2017
|
10.1126/SCITRANSLMED.AAI7993
|
Science Translational Medicine
|
|
Q1
|
|
Artículo en revista científica
|
Efficacy of neoadjuvant carboplatin plus docetaxel in triple-negative breast cancer: Combined analysis of two cohorts
|
Sharma P.
|
2017
|
10.1158/1078-0432.CCR-16-0162
|
Clinical Cancer Research
|
|
Q1
|
|
Journal-article
|
Efficacy of neoadjuvant carboplatin plus docetaxel in triple-negative breast cancer: Combined analysis of two cohorts
|
|
2017
|
10.1158/1078-0432.CCR-16-0162
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts
|
Sharma, Priyanka | Lopez-Tarruella, Sara | Angel Garcia-Saenz, Jose | Ward, Claire | Connor, Carol S. | Gomez, Henry L. | Prat, Aleix | Moreno, Fernando | Jerez-Gilarranz, Yolanda | Barnadas, Augusti | Picornell, Antoni C. | del Monte-Millan, Maria | Gonzalez-Rivera, Milagros | Massarrah, Tatiana | Pelaez-Lorenzo, Beatriz | Isabel Palomero, Maria | Gonzalez del Val, Ricardo | Cortes, Javier | Fuentes Rivera, Hugo | Bretel Morales, Denisse | Marquez-Rodas, Ivan | Perou, Charles M. | Wagner, Jamie L. | Mammen, Joshua M. V. | McGinness, Marilee K. | Klemp, Jennifer R. | Amin, Amanda L. | Fabian, Carol J. | Heldstab, Jaimie | Godwin, Andrew K. | Jensen, Roy A. | Kimler, Bruce F. | Khan, Qamar J. | Martin, Miguel
|
2017
|
10.1158/1078-0432.CCR-16-0162
|
CLINICAL CANCER RESEARCH
|
|
Q1
|
|
Conference Paper
|
Anthracyclines in early breast Cancer: The ABC Trials—USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)
|
Blum J.L.
|
2017
|
10.1200/JCO.2016.71.4147
|
Journal of Clinical Oncology
|
|
No Aplica
|
|
Artículo en revista científica
|
Treatment efficacy, adherence, and quality of life among women younger than 35 years in the international breast cancer study group TEXT and SOFT adjuvant endocrine therapy trials
|
Saha P.
|
2017
|
10.1200/JCO.2016.72.0946
|
Journal of Clinical Oncology
|
|
Q1
|
|
Letter
|
High epidermal growth factor receptor mutation rates in peruvian patients with non–small-cell lung cancer: Is it a matter of asian ancestry?
|
Pinto J.A.
|
2017
|
10.1200/JGO.2016.008201
|
Journal of global oncology
|
|
No Aplica
|
|
Artículo en revista científica
|
Primary cutaneous T-cell lymphoma: Experience from the Peruvian National Cancer Institute
|
Ruiz R.
|
2017
|
10.1590/ABD1806-4841.20176825
|
Anais Brasileiros de Dermatologia
|
|
Q3
|
|
Artículo en revista científica
|
Clinical-pathological features and survival in young women with cervical cancer: A retrospective analysis from the instituto nacional de enfermedades neoplÁsicas
|
Ruiz R.
|
2017
|
10.17843/RPMESP.2017.342.2653
|
Revista Peruana de Medicina de Experimental y Salud Publica
|
|
Q3
|
|
Review
|
Metronomic chemotherapy for non-metastatic triple negative breast cancer: Selection is the key
|
Rabanal C.
|
2017
|
10.5306/WJCO.V8.I6.437
|
World Journal of Clinical Oncology (discontinued)
|
|
Q1
|
|
Journal - Journal Article
|
Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy.
|
Castaneda, Carlos A | Mittendorf, Elizabeth | Casavilca, Sandro | Wu, Yun | Castillo, Miluska | Arboleda, Patricia | Nunez, Teresa | Guerra, Henry | Barrionuevo, Carlos | Dolores-Cerna, Ketty | Belmar-Lopez, Carolina | Abugattas, Julio | Calderon, Gabriela | De La Cruz, Miguel | Cotrina, Manuel | Dunstan, Jorge | Gomez, Henry L | Vidaurre, Tatiana
|
2016
|
|
|
|
S/C***
|
|
Journal-article
|
Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial
|
|
2016
|
10.1007/s10549-016-3792-1
|
|
Scopus to ORCID a través de ORCID
|
|
|
Artículo en revista científica
|
Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial
|
González-Rivera M.
|
2016
|
10.1007/s10549-016-3792-1
|
Breast Cancer Research and Treatment
|
|
Q1
|
|
Journal - Article
|
Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial
|
Gonzalez-Rivera, Milagros | Lobo, Miriam | Lopez-Tarruella, Sara | Jerez, Yolanda | del Monte-Millan, Maria | Massarrah, Tatiana | Ramos-Medina, Rocio | Ocana, Inmaculada | Picornell, Antoni | Santillan Garzon, Sonia | Perez-Carbornero, Lucia | Garcia-Saenz, Jose A. | Gomez, Henry | Moreno, Fernando | Marquez-Rodas, Ivan | Fuentes, Hugo | Martin, Miguel
|
2016
|
10.1007/S10549-016-3792-1
|
BREAST CANCER RESEARCH AND TREATMENT
|
|
Q2
|
|
Journal-article
|
Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial
|
|
2016
|
10.1007/S10549-016-3792-1
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
A Phase II Randomized Study of Lapatinib Combined with Capecitabine, Vinorelbine, or Gemcitabine in Patients with HER2-Positive Metastatic Breast Cancer with Progression after a Taxane (Latin American Cooperative Oncology Group 0801 Study)
|
Gómez H.
|
2016
|
10.1016/j.clbc.2015.10.005
|
Clinical Breast Cancer
|
|
Q2
|
|
Journal-article
|
A Phase II Randomized Study of Lapatinib Combined with Capecitabine, Vinorelbine, or Gemcitabine in Patients with HER2-Positive Metastatic Breast Cancer with Progression after a Taxane (Latin American Cooperative Oncology Group 0801 Study)
|
|
2016
|
10.1016/j.clbc.2015.10.005
|
|
Scopus to ORCID a través de ORCID
|
|
|
Journal-article
|
A Phase II Randomized Study of Lapatinib Combined with Capecitabine, Vinorelbine, or Gemcitabine in Patients with HER2-Positive Metastatic Breast Cancer with Progression after a Taxane (Latin American Cooperative Oncology Group 0801 Study)
|
|
2016
|
10.1016/J.CLBC.2015.10.005
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study)
|
Gomez, Henry L. | Neciosup, Silvia | Tosello, Celia | Mano, Max | Bines, Jose | Ismael, Gustavo | Santi, Patricia X. | Pinczowski, Helio | Neron, Yeni | Fanelli, Marcello | Fein, Luis | Sampaio, Carlos | Lerzo, Guillermo | Capo, Adolfo | Zarba, Juan J. | Blajman, Cesar | Varela, Mirta S. | Martinez-Mesa, Jeovany | Werutsky, Gustavo | Barrios, Carlos H.
|
2016
|
10.1016/J.CLBC.2015.10.005
|
Clinical Breast Cancer
|
|
Q3
|
|
Artículo en revista científica
|
A prognostic signature based on three-genes expression in triple-negative breast tumours with residual disease
|
Pinto J.A.
|
2016
|
10.1038/NPJGENMED.2015.15
|
npj Genomic Medicine
|
|
2016: No disponible**, 2020: Q1
|
|
Journal-article
|
Lapatinib-related rash and breast cancer outcome in the ALTTO phase III randomized trial
|
|
2016
|
10.1093/jnci/djw037
|
|
Scopus to ORCID a través de ORCID
|
|
|
Artículo en revista científica
|
Lapatinib-related rash and breast cancer outcome in the ALTTO phase III randomized trial
|
Sonnenblick A.
|
2016
|
10.1093/jnci/djw037
|
Journal of the National Cancer Institute
|
|
Q1
|
|
Journal-article
|
Lapatinib-related rash and breast cancer outcome in the ALTTO phase III randomized trial
|
|
2016
|
10.1093/JNCI/DJW037
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial
|
Sonnenblick, Amir | de Azambuja, Evandro | Agbor-tarh, Dominique | Bradbury, Ian | Campbell, Christine | Huang, Yingjie | Dueck, Amylou C. | Pritchard, Kathleen I. | Wolff, Antonio C. | Jackisch, Christian | Lang, Istvan | Untch, Michael | Smith, Ian | Boyle, Frances | Xu, Binghe | Gomez, Henry | Perez, Edith A. | Piccart, Martine | Azim, Hatem A., Jr.
|
2016
|
10.1093/JNCI/DJW037
|
JNCI-Journal of the National Cancer Institute
|
|
Q1
|
|
Artículo en revista científica
|
Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence
|
Balko J.M.
|
2016
|
10.1126/scitranslmed.aad3001
|
Science Translational Medicine
|
|
Q1
|
|
Journal-article
|
Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence
|
|
2016
|
10.1126/scitranslmed.aad3001
|
|
Scopus to ORCID a través de ORCID
|
|
|
Journal-article
|
Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence
|
|
2016
|
10.1126/SCITRANSLMED.AAD3001
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence
|
Balko, Justin M. | Schwarz, Luis J. | Luo, Na | Estrada, Monica V. | Giltnane, Jennifer M. | Davila-Gonzalez, Daniel | Wang, Kai | Sanchez, Violeta | Dean, Phillip T. | Combs, Susan E. | Hicks, Donna | Pinto, Joseph A. | Landis, Melissa D. | Doimi, Franco D. | Yelensky, Roman | Miller, Vincent A. | Stephens, Phillip J. | Rimm, David L. | Gomez, Henry | Chang, Jenny C. | Sanders, Melinda E. | Cook, Rebecca S. | Arteaga, Carlos L.
|
2016
|
10.1126/SCITRANSLMED.AAD3001
|
Science Translational Medicine
|
|
Q1
|
|
Review
|
Cancer clinical research in Latin America: Current situation and opportunities. Expert opinion from the first ESMO workshop on clinical trials, Lima, 2015
|
Rolfo C.
|
2016
|
10.1136/ESMOOPEN-2016-000055
|
ESMO Open
|
|
2016: No disponible**, 2020: Q1
|
|
Artículo en revista científica
|
RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: Therapeutic cooperation between MEK and PD-1/PD-L1 immune checkpoint inhibitors
|
Loi S.
|
2016
|
10.1158/1078-0432.CCR-15-1125
|
Clinical Cancer Research
|
|
Q1
|
|
Journal-article
|
RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: Therapeutic cooperation between MEK and PD-1/PD-L1 immune checkpoint inhibitors
|
|
2016
|
10.1158/1078-0432.CCR-15-1125
|
|
Scopus to ORCID a través de ORCID
|
|
|
Journal - Article
|
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors
|
Loi, Sherene | Dushyanthen, Sathana | Beavis, Paul A. | Salgado, Roberto | Denkert, Carsten | Savas, Peter | Combs, Susan | Rimm, David L. | Giltnane, Jennifer M. | Estrada, Monica V. | Sanchez, Violeta | Sanders, Melinda E. | Cook, Rebecca S. | Pilkinton, Mark A. | Mallal, Simon A. | Wang, Kai | Miller, Vincent A. | Stephens, Phil J. | Yelensky, Roman | Doimi, Franco D. | Gomez, Henry | Ryzhov, Sergey V. | Darcy, Phillip K. | Arteaga, Carlos L. | Balko, Justin M.
|
2016
|
10.1158/1078-0432.CCR-15-1125
|
CLINICAL CANCER RESEARCH
|
|
Q1
|
|
Journal-article
|
Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial
|
|
2016
|
10.1186/s13058-016-0771-8
|
|
Scopus to ORCID a través de ORCID
|
|
|
Artículo en revista científica
|
Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial
|
Johansson H.
|
2016
|
10.1186/s13058-016-0771-8
|
Breast Cancer Research
|
|
Q1
|
|
Journal-article
|
Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial
|
|
2016
|
10.1186/S13058-016-0771-8
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
Impact of <i>CYP19A1</i> and <i>ESR1</i> variants on early-onset side effects during combined endocrine therapy in the TEXT trial
|
Johansson, Harriet | Gray, Kathryn P. | Pagani, Olivia | Regan, Meredith M. | Viale, Giuseppe | Aristarco, Valentina | Macis, Debora | Puccio, Antonella | Roux, Susanne | Maibach, Rudolf | Colleoni, Marco | Rabaglio, Manuela | Price, Karen N. | Coates, Alan S. | Gelber, Richard D. | Goldhirsch, Aron | Kammler, Roswitha | Bonanni, Bernardo | Walley, Barbara A.
|
2016
|
10.1186/S13058-016-0771-8
|
|
|
S/C***
|
|
Journal-article
|
Adjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer: Results From the randomized phase III adjuvant lapatinib and/or trastuzumab treatment optimization trial
|
|
2016
|
10.1200/JCO.2015.62.1797
|
|
Scopus to ORCID a través de ORCID
|
|
|
Artículo en revista científica
|
Adjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer: Results From the randomized phase III adjuvant lapatinib and/or trastuzumab treatment optimization trial
|
Piccart-Gebhart M.
|
2016
|
10.1200/JCO.2015.62.1797
|
Journal of Clinical Oncology
|
|
Q1
|
|
Journal - Article
|
Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial
|
Piccart-Gebhart, Martine | Holmes, Eileen | Baselga, Jose | de Azambuja, Evandro | Dueck, Amylou C. | Viale, Giuseppe | Zujewski, Jo Anne | Goldhirsch, Aron | Armour, Alison | Pritchard, Kathleen I. | McCullough, Ann E. | Dolci, Stella | McFadden, Eleanor | Holmes, Andrew P. | Liu Tonghua | Eidtmann, Holger | Phuong Dinh | Di Cosimo, Serena | Harbeck, Nadia | Tjulandin, Sergei | Im, Young-Hyuck | Huang, Chiun-Sheng | Dieras, Veronique | Hillman, David W. | Wolff, Antonio C. | Jackisch, Christian | Lang, Istvan | Untch, Michael | Smith, Ian | Boyle, Frances | Xu, Binghe | Gomez, Henry | Suter, Thomas | Gelber, Richard D. | Perez, Edith A.
|
2016
|
10.1200/JCO.2015.62.1797
|
JOURNAL OF CLINICAL ONCOLOGY
|
|
Q1
|
|
Artículo en revista científica
|
Absolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor-positive, Human epidermal growth factor receptor 2-Negative early breast cancer: TEXT and SOFT Trials
|
Regan M.M.
|
2016
|
10.1200/JCO.2015.64.3171
|
Journal of Clinical Oncology
|
|
Q1
|
|
Journal-article
|
Absolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor-positive, Human epidermal growth factor receptor 2-Negative early breast cancer: TEXT and SOFT Trials
|
|
2016
|
10.1200/JCO.2015.64.3171
|
|
Scopus to ORCID a través de ORCID
|
|
|
Journal - Article
|
Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials
|
Regan, Meredith M. | Francis, Prudence A. | Pagani, Olivia | Fleming, Gini F. | Walley, Barbara A. | Viale, Giuseppe | Colleoni, Marco | Lang, Istvan | Gomez, Henry L. | Tondini, Carlo | Pinotti, Graziella | Price, Karen N. | Coates, Alan S. | Goldhirsch, Aron | Gelber, Richard D.
|
2016
|
10.1200/JCO.2015.64.3171
|
JOURNAL OF CLINICAL ONCOLOGY
|
|
Q1
|
|
Journal-article
|
Low-dose oral cyclophosphamide and methotrexate maintenance for hormone receptor-negative early breast cancer: International Breast Cancer Study Group Trial 22-00
|
|
2016
|
10.1200/JCO.2015.65.6595
|
|
Scopus to ORCID a través de ORCID
|
|
|
Artículo en revista científica
|
Low-dose oral cyclophosphamide and methotrexate maintenance for hormone receptor-negative early breast cancer: International Breast Cancer Study Group Trial 22-00
|
Colleoni M.
|
2016
|
10.1200/JCO.2015.65.6595
|
Journal of Clinical Oncology
|
|
Q1
|
|
Artículo en revista científica
|
Repeated observation of immune gene sets enrichment in women with non-small cell lung cancer
|
Araujo J.M.
|
2016
|
10.18632/oncotarget.7943
|
Oncotarget
|
|
Q1
|
|
Journal-article
|
Repeated observation of immune gene sets enrichment in women with non-small cell lung cancer
|
|
2016
|
10.18632/oncotarget.7943
|
|
Scopus to ORCID a través de ORCID
|
|
|
Journal-article
|
Repeated observation of immune gene sets enrichment in women with non-small cell lung cancer
|
|
2016
|
10.18632/ONCOTARGET.7943
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
Repeated observation of immune gene sets enrichment in women with non-small cell lung cancer
|
Araujo, Jhajaira M. | Prado, Alexandra | Cardenas, Nadezhda K. | Zaharia, Mayer | Dyer, Richard | Doimi, Franco | Bravo, Leny | Pinillos, Luis | Morante, Zaida | Aguilar, Alfredo | Mas, Luis A. | Gomez, Henry L. | Vallejos, Carlos S. | Rolfo, Christian | Pinto, Joseph A.
|
2016
|
10.18632/ONCOTARGET.7943
|
|
|
S/C***
|
|
Journal-article
|
PIK3CA mutated, hormonal receptors and HER2: Individual targets but partnered in the escape to targeted therapy in breast cancer
|
|
2016
|
10.21037/tcr.2016.10.42
|
|
Scopus to ORCID a través de ORCID
|
|
|
Artículo en revista científica
|
PIK3CA mutated, hormonal receptors and HER2: Individual targets but partnered in the escape to targeted therapy in breast cancer
|
Pinto J.
|
2016
|
10.21037/tcr.2016.10.42
|
Translational Cancer Research
|
|
Q2
|
|
Journal-article
|
PIK3CA mutated, hormonal receptors and HER2: Individual targets but partnered in the escape to targeted therapy in breast cancer
|
|
2016
|
10.21037/TCR.2016.10.42
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
PIK<i>3CA</i> mutated, hormonal receptors and HER2: individual targets but partnered in the escape to targeted therapy in breast cancer
|
Pinto, Joseph A. | Gomez, Henry L.
|
2016
|
10.21037/TCR.2016.10.42
|
Translational Cancer Research
|
|
Q4
|
|
Artículo en revista científica
|
Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy
|
Castaneda C.
|
2016
|
10.5306/wjco.v7.i5.387
|
World Journal of Clinical Oncology (discontinued)
|
|
Q1
|
|
Journal-article
|
Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy
|
|
2016
|
10.5306/wjco.v7.i5.387
|
|
Scopus to ORCID a través de ORCID
|
|
|
Journal - Article
|
Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy
|
Castaneda, Carlos A. | Mittendorf, Elizabeth | Casavilca, Sandro | Wu, Yun | Castillo, Miluska | Arboleda, Patricia | Nunez, Teresa | Guerra, Henry | Barrionuevo, Carlos | Dolores-Cerna, Ketty | Belmar-Lopez, Carolina | Abugattas, Julio | Calderon, Gabriela | De La Cruz, Miguel | Cotrina, Manuel | Dunstan, Jorge | Gomez, Henry L. | Vidaurre, Tatiana
|
2016
|
10.5306/WJCO.V7.I5.387
|
|
|
S/C***
|
|
Journal-article
|
Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy
|
|
2016
|
10.5306/WJCO.V7.I5.387
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy
|
Moore H.C.F.
|
2015
|
10.1056/NEJMoa1413204
|
New England Journal of Medicine
|
|
Q1
|
|
Journal-article
|
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy
|
|
2015
|
10.1056/NEJMOA1413204
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy
|
Moore, Halle C. F. | Unger, Joseph M. | Phillips, Kelly-Anne | Boyle, Frances | Hitre, Erika | Porter, David | Francis, Prudence A. | Goldstein, Lori J. | Gomez, Henry L. | Vallejos, Carlos S. | Partridge, Ann H. | Dakhil, Shaker R. | Garcia, Agustin A. | Gralow, Julie | Lombard, Janine M. | Forbes, John F. | Martino, Silvana | Barlow, William E. | Fabian, Carol J. | Minasian, Lori | Meyskens, Frank L., Jr. | Gelber, Richard D. | Hortobagyi, Gabriel N. | Albain, Kathy S.
|
2015
|
10.1056/NEJMOA1413204
|
NEW ENGLAND JOURNAL OF MEDICINE
|
|
Q1
|
|
Artículo en revista científica
|
Prospective validation of a 21-gene expression assay in breast cancer
|
Sparano J.A.
|
2015
|
10.1056/NEJMoa1510764
|
New England Journal of Medicine
|
|
Q1
|
|
Journal-article
|
Prospective validation of a 21-gene expression assay in breast cancer
|
|
2015
|
10.1056/NEJMOA1510764
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
|
Sparano, J. A. | Gray, R. J. | Makower, D. F. | Pritchard, K. I. | Albain, K. S. | Hayes, D. F. | Geyer, C. E., Jr. | Dees, E. C. | Perez, E. A. | Olson, J. A., Jr. | Zujewski, J. A. | Lively, T. | Badve, S. S. | Saphner, T. J. | Wagner, L. I. | Whelan, T. J. | Ellis, M. J. | Paik, S. | Wood, W. C. | Ravdin, P. | Keane, M. M. | Gomez Moreno, H. L. | Reddy, P. S. | Goggins, T. F. | Mayer, I. A. | Brufsky, A. M. | Toppmeyer, D. L. | Kaklamani, V. G. | Atkins, J. N. | Berenberg, J. L. | Sledge, G. W.
|
2015
|
10.1056/NEJMOA1510764
|
NEW ENGLAND JOURNAL OF MEDICINE
|
|
Q1
|
|
Artículo en revista científica
|
Loss of heterozygosity at the CYP2D6 locus in breast cancer: Implications for germline pharmacogenetic studies
|
Goetz M.P.
|
2015
|
10.1093/jnci/dju401
|
Journal of the National Cancer Institute
|
|
Q1
|
|
Journal-article
|
Loss of heterozygosity at the CYP2D6 locus in breast cancer: Implications for germline pharmacogenetic studies
|
|
2015
|
10.1093/JNCI/DJU401
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
Loss of Heterozygosity at the <i>CYP2D6</i> Locus in Breast Cancer: Implications for Germline Pharmacogenetic Studies
|
Goetz, Matthew P. | Sun, James X. | Suman, Vera J. | Silva, Grace O. | Perou, Charles M. | Nakamura, Yusuke | Cox, Nancy J. | Stephens, Philip J. | Miller, Vincent A. | Ross, Jeffrey S. | Chen, David | Safgren, Stephanie L. | Kuffel, Mary J. | Ames, Matthew M. | Kalari, Krishna R. | Gomez, Henry L. | Gonzalez-Angulo, Ana M. | Burgues, Octavio | Brauch, Hiltrud B. | Ingle, James N. | Ratain, Mark J. | Yelensky, Roman
|
2015
|
10.1093/JNCI/DJU401
|
JNCI-Journal of the National Cancer Institute
|
|
Q1
|
|
Note
|
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy
|
Moore H.C.F.
|
2015
|
10.1097/01.ogx.0000467230.21869.a4
|
Obstetrical and Gynecological Survey
|
|
No Aplica
|
|
Journal-article
|
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy
|
|
2015
|
10.1097/01.OGX.0000467230.21869.A4
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Editorial Material
|
Goserelin for Ovarian Protection During Breast-Cancer Adjuvant Chemotherapy
|
Moore, Halle C. F. | Unger, Joseph M. | Phillips, Kelly-Anne | Boyle, Frances | Hitre, Erika | Porter, David | Francis, Prudence A. | Goldstein, Lori J. | Gomez, Henry L. | Vallejos, Carlos S. | Partridge, Ann H. | Dakhil, Shaker R. | Garcia, Agustin A. | Gralow, Julie | Lombard, Janine M. | Forbe, John F. | Martino, Silvana | Barlow, William E. | Fabian, Carol J. | Minasian, Lori | Meyskens, Frank L., Jr. | Gelber, Richard D. | Hortobagyi, Gabriel N. | Albain, Kathy S.
|
2015
|
10.1097/01.OGX.0000467230.21869.A4
|
OBSTETRICAL & GYNECOLOGICAL SURVEY
|
|
Q3
|
|
Journal-article
|
Prognostic factors for patients with newly diagnosed brain metastasis from breast cancer
|
|
2015
|
10.2217/CNS.15.5
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Prognostic factors for patients with newly diagnosed brain metastasis from breast cancer
|
Castaneda C.
|
2015
|
10.2217/CNS.15.5
|
CNS oncology
|
|
Q3
|
|
Journal - Journal Article
|
Prognostic factors for patients with newly diagnosed brain metastasis from breast cancer.
|
Castaneda, Carlos A | Flores, Raymundo | Rojas, Katerin Y | Castillo, Miluska | Dolores-Cerna, Ketty | Flores, Claudio | Belmar-Lopez, Carolina | Milla, Esperanza | Gomez, Henry
|
2015
|
10.2217/CNS.15.5
|
|
|
S/C***
|
|
Artículo en revista científica
|
Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial.
|
Piccart-Gebhart M
|
2015
|
|
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
|
|
No Aplica
|
|
Artículo en revista científica
|
Prognostic factors for patients with newly diagnosed brain metastasis from breast cancer.
|
Castaneda CA
|
2015
|
|
CNS oncology
|
|
No Aplica
|
|
Artículo en revista científica
|
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors.
|
Loi S
|
2015
|
|
Clinical cancer research : an official journal of the American Association for Cancer Research
|
|
No Aplica
|
|
Artículo en revista científica
|
Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3-98
|
Senkus E.
|
2014
|
10.1002/pon.3384
|
Psycho-Oncology
|
|
Q1
|
|
Journal - Article
|
Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3-98
|
Senkus, Elzbieta | Gomez, Henry | Dirix, Luc | Jerusalem, Guy | Murray, Elizabeth | Van Tienhoven, Geertjan | Westenberg, A. Helen | Bottomley, Andrew | Rapion, Jerome | Bogaerts, Jan | Di Leo, Angelo | Neskovic-Konstantinovic, Zora
|
2014
|
10.1002/PON.3384
|
PSYCHO-ONCOLOGY
|
|
Q1
|
|
Journal-article
|
Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3-98
|
|
2014
|
10.1002/PON.3384
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal-article
|
PIK3CA mutations in Peruvian patients with HER2-amplified and triple negative non-metastatic breast cancers
|
|
2014
|
10.1016/J.HEMONC.2014.09.007
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
PIK3CA mutations in Peruvian patients with HER2-amplified and triple negative non-metastatic breast cancers
|
Castaneda C.A.
|
2014
|
10.1016/J.HEMONC.2014.09.007
|
Hematology/ Oncology and Stem Cell Therapy
|
|
Q3
|
|
Journal - Journal Article
|
PIK3CA mutations in Peruvian patients with HER2-amplified and triple negative non-metastatic breast cancers.
|
Castaneda, Carlos A | Lopez-Ilasaca, Marco | Pinto, Joseph A | Chirinos-Arias, Michelle | Doimi, Franco | Neciosup, Silvia P | Rojas, Katerin I | Vidaurre, Tatiana | Balko, Justin M | Arteaga, Carlos L | Gomez, Henry L
|
2014
|
10.1016/J.HEMONC.2014.09.007
|
|
|
S/C***
|
|
Artículo en revista científica
|
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer
|
Pagani O.
|
2014
|
10.1056/NEJMoa1404037
|
New England Journal of Medicine
|
|
Q1
|
|
Journal-article
|
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer
|
|
2014
|
10.1056/NEJMOA1404037
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|
Pagani, Olivia | Regan, Meredith M. | Walley, Barbara A. | Fleming, Gini F. | Colleoni, Marco | Lang, Istvan | Gomez, Henry L. | Tondini, Carlo | Burstein, Harold J. | Perez, Edith A. | Ciruelos, Eva | Stearns, Vered | Bonnefoi, Herve R. | Martino, Silvana | Geyer, Charles E., Jr. | Pinotti, Graziella | Puglisi, Fabio | Crivellari, Diana | Ruhstaller, Thomas | Winer, Eric P. | Rabaglio-Poretti, Manuela | Maibach, Rudolf | Ruepp, Barbara | Giobbie-Hurder, Anita | Price, Karen N. | Bernhard, Juerg | Luo, Weixiu | Ribi, Karin | Viale, Giuseppe | Coates, Alan S. | Gelber, Richard D. | Goldhirsch, Aron | Francis, Prudence A.
|
2014
|
10.1056/NEJMOA1404037
|
NEW ENGLAND JOURNAL OF MEDICINE
|
|
Q1
|
|
Artículo en revista científica
|
Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancer
|
Jeselsohn R.
|
2014
|
10.1158/1078-0432.CCR-13-2332
|
Clinical Cancer Research
|
|
Q1
|
|
Journal-article
|
Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancer
|
|
2014
|
10.1158/1078-0432.CCR-13-2332
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer
|
Jeselsohn, Rinath | Yelensky, Roman | Buchwalter, Gilles | Frampton, Garrett | Meric-Bernstam, Funda | Gonzalez-Angulo, Ana Maria | Ferrer-Lozano, Jaime | Perez-Fidalgo, Jose A. | Cristofanilli, Massimo | Gomez, Henry | Arteaga, Carlos L. | Giltnane, Jennifer | Balko, Justin M. | Cronin, Maureen T. | Jarosz, Mirna | Sun, James | Hawryluk, Matthew | Lipson, Doron | Otto, Geoff | Ross, Jeffrey S. | Dvir, Addie | Soussan-Gutman, Lior | Wolf, Ido | Rubinek, Tamar | Gilmore, Lauren | Schnitt, Stuart | Come, Steven E. | Pusztai, Lajos | Stephens, Philip | Brown, Myles | Miller, Vincent A.
|
2014
|
10.1158/1078-0432.CCR-13-2332
|
CLINICAL CANCER RESEARCH
|
|
Q1
|
|
Journal-article
|
Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets
|
|
2014
|
10.1158/2159-8290.CD-13-0286
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets
|
Balko J.M.
|
2014
|
10.1158/2159-8290.CD-13-0286
|
Cancer Discovery
|
|
Q1
|
|
Journal - Article
|
Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets
|
Balko, Justin M. | Giltnane, Jennifer M. | Wang, Kai | Schwarz, Luis J. | Young, Christian D. | Cook, Rebecca S. | Owens, Phillip | Sanders, Melinda E. | Kuba, Maria G. | Sanchez, Violeta | Kurupi, Richard | Moore, Preston D. | Pinto, Joseph A. | Doimi, Franco D. | Gomez, Henry | Horiuchi, Dai | Goga, Andrei | Lehmann, Brian D. | Bauer, Joshua A. | Pietenpol, Jennifer A. | Ross, Jeffrey S. | Palmer, Gary A. | Yelensky, Roman | Cronin, Maureen | Miller, Vincent A. | Stephens, Phillip J. | Arteaga, Carlos L.
|
2014
|
10.1158/2159-8290.CD-13-0286
|
Cancer Discovery
|
|
Q1
|
|
Artículo en revista científica
|
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
|
Lehmann B.D.
|
2014
|
10.1186/s13058-014-0406-x
|
Breast Cancer Research
|
|
Q1
|
|
Journal-article
|
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
|
|
2014
|
10.1186/S13058-014-0406-X
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
|
Lehmann, Brian D. | Bauer, Joshua A. | Schafer, Johanna M. | Pendleton, Christopher S. | Tang, Luojia | Johnson, Kimberly C. | Chen, Xi | Balko, Justin M. | Gomez, Henry | Arteaga, Carlos L. | Mills, Gordon B. | Sanders, Melinda E. | Pietenpol, Jennifer A.
|
2014
|
10.1186/S13058-014-0406-X
|
|
|
2014: No disponible**, 2020: Q1
|
|
Artículo en revista científica
|
Advanced extramammary Paget's disease of the groin, penis, and scrotum
|
Isrow D.
|
2014
|
10.4137/CMO.S13107
|
Clinical Medicine Insights: Oncology
|
|
Q3
|
|
Journal-article
|
Advanced extramammary Pagets disease of the groin, penis, and scrotum
|
|
2014
|
10.4137/CMO.S13107
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Case Reports
|
Advanced Extramammary Paget's Disease of the Groin, Penis, and Scrotum.
|
Isrow, Derek | Oregel, Karlos Z | Cortes, Javier | Gomez, Henry | Milikowski, Clara | Feun, Lynn | Silva, Orlando
|
2014
|
10.4137/CMO.S13107
|
|
|
S/C***
|
|
Artículo en revista científica
|
A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer
|
Cristofanilli M.
|
2013
|
10.1007/s10549-012-2369-x
|
Breast Cancer Research and Treatment
|
|
Q1
|
|
Journal-article
|
A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer
|
|
2013
|
10.1007/S10549-012-2369-X
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
A randomized phase II study of lapatinib plus pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer
|
Cristofanilli, Massimo | Johnston, Stephen R. D. | Manikhas, Alexey | Gomez, Henry L. | Gladkov, Oleg | Shao, Zhimin | Safina, Sufia | Blackwell, Kimberly L. | Alvarez, Ricardo H. | Rubin, Stephen D. | Ranganathan, Sulabha | Redhu, Suman | Trudeau, Maureen E.
|
2013
|
10.1007/S10549-012-2369-X
|
BREAST CANCER RESEARCH AND TREATMENT
|
|
Q1
|
|
Artículo en revista científica
|
A randomized and open-label trial evaluating the addition of pazopanib to lapatinib as first-line therapy in patients with HER2-positive advanced breast cancer
|
Johnston S.R.D.
|
2013
|
10.1007/s10549-012-2399-4
|
Breast Cancer Research and Treatment
|
|
Q1
|
|
Journal-article
|
A randomized and open-label trial evaluating the addition of pazopanib to lapatinib as first-line therapy in patients with HER2-positive advanced breast cancer
|
|
2013
|
10.1007/S10549-012-2399-4
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
A randomized and open-label trial evaluating the addition of pazopanib to lapatinib as first-line therapy in patients with HER2-positive advanced breast cancer
|
Johnston, Stephen R. D. | Gomez, Henry | Stemmer, Salomon M. | Richie, Maria | Durante, Michael | Pandite, Lini | Goodman, Vicki | Slamon, Dennis
|
2013
|
10.1007/S10549-012-2399-4
|
BREAST CANCER RESEARCH AND TREATMENT
|
|
Q1
|
|
Artículo en revista científica
|
Efficacy and safety of ixabepilone plus capecitabine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer
|
Vahdat L.T.
|
2013
|
10.1016/j.jgo.2013.07.006
|
Journal of Geriatric Oncology
|
|
Q2
|
|
Journal-article
|
Efficacy and safety of ixabepilone plus capecitabine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer
|
|
2013
|
10.1016/J.JGO.2013.07.006
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
Efficacy and safety of ixabepilone plus capecitabine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer
|
Vahdat, Linda T. | Vrdoljak, Eduard | Gomez, Henry | Li, Rubi Khaw | Bosserman, Linda | Sparano, Joseph A. | Baselga, Jose | Mukhopadhyay, Pralay | Valero, Vicente
|
2013
|
10.1016/J.JGO.2013.07.006
|
Journal of Geriatric Oncology
|
|
Q3
|
|
Journal - Article
|
Planning cancer control in Latin America and the Caribbean
|
Goss, Paul E. | Lee, Brittany L. | Badovinac-Crnjevic, Tanja | Strasser-Weippl, Kathrin | Chavarri-Guerra, Yanin | St Louis, Jessica | Villarreal-Garza, Cynthia | Unger-Saldana, Karla | Ferreyra, Mayra | Debiasi, Marcio | Liedke, Pedro E. R. | Touya, Diego | Werutsky, Gustavo | Higgins, Michaela | Fan, Lei | Vasconcelos, Claudia | Cazap, Eduardo | Vallejos, Carlos | Mohar, Alejandro | Knaul, Felicia | Arreola, Hector | Batura, Rekha | Luciani, Silvana | Sullivan, Richard | Finkelstein, Dianne | Simon, Sergio | Barrios, Carlos | Kightlinger, Rebecca | Gelrud, Andres | Bychkovsky, Vladimir | Lopes, Gilberto | Stefani, Stephen | Blaya, Marcelo | Souza, Fabiano Hahn | Santos, Franklin Santana | Kaemmerer, Alberto | de Azambuja, Evandro | Cardona Zorilla, Andres Felipe | Murillo, Raul | Jeronimo, Jose | Tsu, Vivien | Carvalho, Andre | Gil, Carlos Ferreira | Sternberg, Cinthya | Duenas-Gonzalez, Alfonso | Sgroi, Dennis | Cuello, Mauricio | Fresco, Rodrigo | Reis, Rui Manuel | Masera, Guiseppe | Gabus, Raul | Ribeiro, Raul | Knust, Renata | Ismael, Gustavo | Rosenblatt, Eduardo | Roth, Berta | Villa, Luisa | Lara Solares, Argelia | Ximena Leon, Marta | Torres-Vigil, Isabel | Covarrubias-Gomez, Alfredo | Hernandez, Andres | Bertolino, Mariela | Schwartsmann, Gilberto | Santillana, Sergio | Esteva, Francisco | Fein, Luis | Mano, Max | Gomez, Henry | Hurlbert, Marc | Durstine, Alessandra | Azenha, Gustavo
|
2013
|
10.1016/S1470-2045(13)70048-2
|
LANCET ONCOLOGY
|
|
Q1
|
|
Review
|
Planning cancer control in Latin America and the Caribbean
|
Goss P.E.
|
2013
|
10.1016/S1470-2045(13)70048-2
|
Lancet Oncology, The
|
|
Q1
|
|
Journal-article
|
Planning cancer control in Latin America and the Caribbean
|
|
2013
|
10.1016/S1470-2045(13)70048-2
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal-article
|
Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer
|
|
2013
|
10.1158/0008-5472.CAN-13-1385
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer
|
Balko J.
|
2013
|
10.1158/0008-5472.CAN-13-1385
|
Cancer Research
|
|
Q1
|
|
Journal - Article
|
Activation of MAPK Pathways due to DUSP4 Loss Promotes Cancer Stem Cell-like Phenotypes in Basal-like Breast Cancer
|
Balko, Justin M. | Schwarz, Luis J. | Bhola, Neil E. | Kurupi, Richard | Owens, Phillip | Miller, Todd W. | Gomez, Henry | Cook, Rebecca S. | Arteaga, Carlos L.
|
2013
|
10.1158/0008-5472.CAN-13-1385
|
CANCER RESEARCH
|
|
Q1
|
|
Journal-article
|
Lactate dehydrogenase B: A metabolic marker of response to neoadjuvant chemotherapy in breast cancer
|
|
2013
|
10.1158/1078-0432.CCR-13-0623
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Lactate dehydrogenase B: A metabolic marker of response to neoadjuvant chemotherapy in breast cancer
|
Dennison J.B.
|
2013
|
10.1158/1078-0432.CCR-13-0623
|
Clinical Cancer Research
|
|
Q1
|
|
Journal - Article
|
Lactate Dehydrogenase B: A Metabolic Marker of Response to Neoadjuvant Chemotherapy in Breast Cancer
|
Dennison, Jennifer B. | Molina, Jennifer R. | Mitra, Shreya | Gonzalez-Angulo, Ana M. | Balko, Justin M. | Kuba, Maria G. | Sanders, Melinda E. | Pinto, Joseph A. | Gomez, Henry L. | Arteaga, Carlos L. | Brown, Robert E. | Mills, Gordon B.
|
2013
|
10.1158/1078-0432.CCR-13-0623
|
CLINICAL CANCER RESEARCH
|
|
Q1
|
|
Journal - Article
|
A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trial
|
Baselga, Jose | Costa, Frederico | Gomez, Henry | Hudis, Clifford A. | Rapoport, Bernardo | Roche, Henri | Schwartzberg, Lee S. | Petrenciuc, Oana | Shan, Minghua | Gradishar, William J.
|
2013
|
10.1186/1745-6215-14-228
|
Trials
|
|
Q3
|
|
Artículo en revista científica
|
A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): Study protocol for a randomized controlled trial
|
Baselga J.
|
2013
|
10.1186/1745-6215-14-228
|
Trials
|
|
Q1
|
|
Journal-article
|
A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): Study protocol for a randomized controlled trial
|
|
2013
|
10.1186/1745-6215-14-228
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal-article
|
Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer.
|
|
2013
|
10.1200/JCO.2011.40.5241
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2–overexpressing metastatic breast cancer
|
Guan Z.
|
2013
|
10.1200/JCO.2011.40.5241
|
Journal of Clinical Oncology
|
|
Q1
|
|
Journal - Article
|
Randomized Trial of Lapatinib Versus Placebo Added to Paclitaxel in the Treatment of Human Epidermal Growth Factor Receptor 2-Overexpressing Metastatic Breast Cancer
|
Guan, Zhongzhen | Xu, Binghe | DeSilvio, Michelle L. | Shen, Zhenzhou | Arpornwirat, Wichit | Tong, Zhongsheng | Lorvidhaya, Vicharn | Jiang, Zefei | Yang, Junlan | Makhson, Anatoly | Leung, Wai Lim | Russo, Mark W. | Newstat, Beth | Wang, Li | Chen, George | Oliva, Cristina | Gomez, Henry
|
2013
|
10.1200/JCO.2011.40.5241
|
JOURNAL OF CLINICAL ONCOLOGY
|
|
Q1
|
|
Review
|
Neoadyuvant chemotherapy in the treatment of locally advanced breast cancer
|
Zaharia M.
|
2013
|
10.1590/S1726-46342013000100015
|
Revista Peruana de Medicina de Experimental y Salud Publica
|
|
Q3
|
|
Journal-article
|
Neoadyuvant chemotherapy in the treatment of locally advanced breast cancer | La quimioterapia neoadyuvante en el tratamiento del cáncer de mama localmente avanzado
|
|
2013
|
10.1590/S1726-46342013000100015
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Breast cancer in young women in latin america: An unmet, growing burden
|
Villarreal-Garza C.
|
2013
|
10.1634/THEONCOLOGIST.18-S2-26
|
Oncologist
|
|
Q1
|
|
Journal-article
|
Breast cancer in young women in latin america: An unmet, growing burden
|
|
2013
|
10.1634/THEONCOLOGIST.18-S2-26
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Breast cancer in young women in Latin America: An Unmet, growing Burden
|
Villarreal-Garza C.
|
2013
|
10.1634/theoncologist.2013-0321
|
Oncologist
|
|
Q1
|
|
Journal-article
|
Breast cancer in young women in Latin America: An Unmet, growing Burden
|
|
2013
|
10.1634/THEONCOLOGIST.2013-0321
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
Breast Cancer in Young Women in Latin America: An Unmet, Growing Burden
|
Villarreal-Garza, Cynthia | Aguila, Christian | Magallanes-Hoyos, Amaria C. | Mohar, Alejandro | Bargallo, Enrique | Meneses, Abelardo | Cazap, Eduardo | Gomez, Henry | Lopez-Carrillo, Lizbeth | Chavarri-Guerra, Yanin | Murillo, Raul | Barrios, Carlos
|
2013
|
10.1634/THEONCOLOGIST.2013-0321
|
ONCOLOGIST
|
|
Q1
|
|
Artículo en revista científica
|
Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkins lymphoma
|
Ribrag V.
|
2013
|
10.3324/haematol.2012.069757
|
Haematologica
|
|
Q1
|
|
Journal - Article
|
Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma
|
Ribrag, Vincent | Caballero, Dolores | Ferme, Christophe | Zucca, Emanuele | Arranz, Reyes | Briones, Javier | Gisselbrecht, Christian | Salles, Gilles | Gianni, Alessandro M. | Gomez, Henry | Kahatt, Carmen | Corrado, Claudia | Szyldergemajn, Sergio | Extremera, Sonia | de Miguel, Bernardo | Cullell-Young, Martin | Cavalli, Franco
|
2013
|
10.3324/HAEMATOL.2012.069757
|
|
|
S/C***
|
|
Journal-article
|
Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkins lymphoma
|
|
2013
|
10.3324/HAEMATOL.2012.069757
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal-article
|
Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma: A phase II trial showing reduction in toxicity without altering long-term survival
|
|
2013
|
10.5144/1658-3876.2012.152
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal-article
|
Ixabepilone treatment in young patients with breast cancer. A Latin American experience | Tratando pacientes jóvenes con cáncer de mama con ixabepilona experiencia latino americana
|
|
2013
|
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal-article
|
Triple negative breast cancer: A difficult disease to diagnose and treat | Cáncer de mama triple negativo: Una enfermedad de difícil diagnóstico y tratamiento
|
|
2013
|
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Ixabepilone treatment in young patients with breast cancer. A Latin American experience
|
Cardona A.F.
|
2013
|
|
Revista Venezolana de Oncologia
|
|
Q4
|
|
Review
|
Triple negative breast cancer: A difficult disease to diagnose and treat
|
Zaharia M.
|
2013
|
|
Revista Peruana de Medicina de Experimental y Salud Publica
|
|
Q3
|
|
Artículo en revista científica
|
A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer
|
Carlson R.W.
|
2012
|
10.1007/S10549-012-1997-5
|
Breast Cancer Research and Treatment
|
|
Q1
|
|
Journal - Article
|
A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer
|
Carlson, Robert W. | O'Neill, Anne | Vidaurre, Tatiana | Gomez, Henry L. | Badve, Sunil S. | Sledge, George W.
|
2012
|
10.1007/S10549-012-1997-5
|
BREAST CANCER RESEARCH AND TREATMENT
|
|
Q1
|
|
Journal-article
|
A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer
|
|
2012
|
10.1007/S10549-012-1997-5
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers
|
Santarpia L.
|
2012
|
10.1007/s10549-012-2035-3
|
Breast Cancer Research and Treatment
|
|
Q1
|
|
Journal - Article
|
Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers
|
Santarpia, Libero | Qi, Yuan | Stemke-Hale, Katherine | Wang, Bailiang | Young, Elliana J. | Booser, Daniel J. | Holmes, Frankie A. | O'Shaughnessy, Joyce | Hellerstedt, Beth | Pippen, John | Vidaurre, Tatiana | Gomez, Henry | Valero, Vicente | Hortobagyi, Gabriel N. | Symmans, W. Fraser | Bottai, Giulia | Di Leo, Angelo | Gonzalez-Angulo, Ana M. | Pusztai, Lajos
|
2012
|
10.1007/S10549-012-2035-3
|
BREAST CANCER RESEARCH AND TREATMENT
|
|
Q1
|
|
Journal-article
|
Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers
|
|
2012
|
10.1007/S10549-012-2035-3
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Behaviour of breast cancer molecular subtypes through tumour progression
|
Castaneda C.A.
|
2012
|
10.1007/s12094-012-0827-x
|
Clinical and Translational Oncology
|
|
Q2
|
|
Journal-article
|
Behaviour of breast cancer molecular subtypes through tumour progression
|
|
2012
|
10.1007/S12094-012-0827-X
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
Behaviour of breast cancer molecular subtypes through tumour progression
|
Castaneda, Carlos A. | Andres, Eva | Barcena, Carmen | Gomez, Henry L. | Cortes-Funes, Hernan | Ciruelos, Eva
|
2012
|
10.1007/S12094-012-0827-X
|
Clinical & Translational Oncology
|
|
Q4
|
|
Artículo en revista científica
|
Small-cell cancer of the breast: What is the optimal treatment? A report and review of outcomes
|
Ochoa R.
|
2012
|
10.1016/J.CLBC.2012.03.007
|
Clinical Breast Cancer
|
|
Q1
|
|
Journal-article
|
Small-cell cancer of the breast: What is the optimal treatment? A report and review of outcomes
|
|
2012
|
10.1016/J.CLBC.2012.03.007
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Review
|
Small-Cell Cancer of the Breast: What Is the Optimal Treatment? A Report and Review of Outcomes
|
Ochoa, Roberto | Sudhindra, Ashkay | Garcia-Buitrago, Monica | Romilly, Ada P. | Cortes, Javier | Gomez, Henry | Rocha Lima, Caio Max | Silva, Orlando
|
2012
|
10.1016/J.CLBC.2012.03.007
|
Clinical Breast Cancer
|
|
Q3
|
|
Artículo en revista científica
|
Maintenance of clinical efficacy after dose reduction of ixabepilone plus capecitabine in patients with anthracycline- and taxane-resistant metastatic breast cancer: A retrospective analysis of pooled data from 2 phase III randomized clinical trials
|
Valero V.
|
2012
|
10.1016/j.clbc.2012.03.013
|
Clinical Breast Cancer
|
|
Q1
|
|
Journal-article
|
Maintenance of clinical efficacy after dose reduction of ixabepilone plus capecitabine in patients with anthracycline- and taxane-resistant metastatic breast cancer: A retrospective analysis of pooled data from 2 phase III randomized clinical trials
|
|
2012
|
10.1016/J.CLBC.2012.03.013
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
Maintenance of Clinical Efficacy After Dose Reduction of Ixabepilone Plus Capecitabine in Patients With Anthracycline- and Taxane-Resistant Metastatic Breast Cancer: A Retrospective Analysis of Pooled Data From 2 Phase III Randomized Clinical Trials
|
Valero, Vicente | Vrdoljak, Eduard | Xu, Binghe | Thomas, Eva | Gomez, Henry | Manikhas, Alexey | Medina, Carlos | Li, Rubi Khaw | Ro, Jungsil | Bosserman, Linda | Vahdat, Linda | Mukhopadhyay, Pralay | Opatt, Diane | Sparano, Joseph A.
|
2012
|
10.1016/J.CLBC.2012.03.013
|
Clinical Breast Cancer
|
|
Q3
|
|
Journal - Article
|
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
|
Baselga, Jose | Bradbury, Ian | Eidtmann, Holger | Di Cosimo, Serena | de Azambuja, Evandro | Aura, Claudia | Gomez, Henry | Dinh, Phuong | Fauria, Karine | Van Dooren, Veerle | Aktan, Gursel | Goldhirsch, Aron | Chang, Tsai-Wang | Horvath, Zsolt | Coccia-Portugal, Maria | Domont, Julien | Tseng, Ling-Min | Kunz, Georg | Sohn, Joo Hyuk | Semiglazov, Vladimir | Lerzo, Guillermo | Palacova, Marketa | Probachai, Volodymyr | Pusztai, Lajos | Untch, Michael | Gelber, Richard D. | Piccart-Gebhart, Martine
|
2012
|
10.1016/S0140-6736(11)61847-3
|
LANCET
|
|
Q1
|
|
Journal-article
|
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): A randomised, open-label, multicentre, phase 3 trial
|
|
2012
|
10.1016/S0140-6736(11)61847-3
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Conference Paper
|
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): A randomised, open-label, multicentre, phase 3 trial
|
Baselga J.
|
2012
|
10.1016/S0140-6736(11)61847-3
|
Lancet, The
|
|
No Aplica
|
|
Journal - Article
|
Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial
|
Pettengell, Ruth | Coiffier, Bertrand | Narayanan, Geetha | Hurtado de Mendoza, Fernando | Digumarti, Raghunadharao | Gomez, Henry | Zinzani, Pier Luigi | Schiller, Gary | Rizzieri, David | Boland, Giles | Cernohous, Paul | Wang, Lixia | Kuepfer, Christine | Gorbatchevsky, Igor | Singer, Jack W.
|
2012
|
10.1016/S1470-2045(12)70212-7
|
LANCET ONCOLOGY
|
|
Q1
|
|
Journal-article
|
Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: A phase 3, multicentre, open-label, randomised trial
|
|
2012
|
10.1016/S1470-2045(12)70212-7
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: A phase 3, multicentre, open-label, randomised trial
|
Pettengell R.
|
2012
|
10.1016/S1470-2045(12)70212-7
|
Lancet Oncology, The
|
|
Q1
|
|
Artículo en revista científica
|
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance
|
Balko J.M.
|
2012
|
10.1038/nm.2795
|
Nature Medicine
|
|
Q1
|
|
Journal - Article
|
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance
|
Balko, Justin M. | Cook, Rebecca S. | Vaught, David B. | Kuba, Maria G. | Miller, Todd W. | Bhola, Neil E. | Sanders, Melinda E. | Granja-Ingram, Nara M. | Smith, J. Joshua | Meszoely, Ingrid M. | Salter, Janine | Dowsett, Mitch | Stemke-Hale, Katherine | Gonzalez-Angulo, Ana M. | Mills, Gordon B. | Pinto, Joseph A. | Gomez, Henry L. | Arteaga, Carlos L.
|
2012
|
10.1038/NM.2795
|
NATURE MEDICINE
|
|
Q1
|
|
Journal-article
|
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance
|
|
2012
|
10.1038/NM.2795
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Phase I dose-escalation and pharmacokinetic study of ispinesib, a kinesin spindle protein inhibitor, administered on days 1 and 15 of a 28-day schedule in patients with no prior treatment for advanced breast cancer
|
Gomez H.L.
|
2012
|
10.1097/CAD.0b013e32834e74d6
|
Anti-Cancer Drugs
|
|
Q1
|
|
Journal - Article
|
Phase I dose-escalation and pharmacokinetic study of ispinesib, a kinesin spindle protein inhibitor, administered on days 1 and 15 of a 28-day schedule in patients with no prior treatment for advanced breast cancer
|
Gomez, Henry L. | Philco, Manuel | Pimentel, Patricia | Kiyan, Miriam | Monsalvo, Maria Laura | Conlan, Maureen G. | Saikali, Khalil G. | Chen, Michael M. | Seroogy, Joseph J. | Wolff, Andrew A. | Escandon, Rafael D.
|
2012
|
10.1097/CAD.0B013E32834E74D6
|
ANTI-CANCER DRUGS
|
|
Q2
|
|
Journal-article
|
Phase I dose-escalation and pharmacokinetic study of ispinesib, a kinesin spindle protein inhibitor, administered on days 1 and 15 of a 28-day schedule in patients with no prior treatment for advanced breast cancer
|
|
2012
|
10.1097/CAD.0B013E32834E74D6
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma: A phase II trial showing reduction in toxicity without altering long-term survival
|
Gómez H.L.
|
2012
|
10.5144/1658-3876.2012.152
|
Hematology/ Oncology and Stem Cell Therapy
|
|
Q3
|
|
Artículo en revista científica
|
A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer
|
Hatzis C.
|
2011
|
10.1001/jama.2011.593
|
JAMA - Journal of the American Medical Association
|
|
Q1
|
|
Journal-article
|
A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer
|
|
2011
|
10.1001/JAMA.2011.593
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
|
Hatzis, Christos | Pusztai, Lajos | Valero, Vicente | Booser, Daniel J. | Esserman, Laura | Lluch, Ana | Vidaurre, Tatiana | Holmes, Frankie | Souchon, Eduardo | Wang, Hongkun | Martin, Miguel | Cotrina, Jose | Gomez, Henry | Hubbard, Rebekah | Ignacio Chacon, J. | Ferrer-Lozano, Jaime | Dyer, Richard | Buxton, Meredith | Gong, Yun | Wu, Yun | Ibrahim, Nuhad | Andreopoulou, Eleni | Ueno, Naoto T. | Hunt, Kelly | Yang, Wei | Nazario, Arlene | DeMichele, Angela | O'Shaughnessy, Joyce | Hortobagyi, Gabriel N. | Symmans, W. Fraser
|
2011
|
10.1001/JAMA.2011.593
|
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
|
Q1
|
|
Artículo en revista científica
|
Topoisomerase II-α as a predictive factor of response to therapy with anthracyclines in locally advanced breast cancer
|
Gómez H.
|
2011
|
10.1016/j.breast.2010.06.009
|
Breast
|
|
Q1
|
|
Journal - Article
|
Topoisomerase II-α as a predictive factor of response to therapy with anthracyclines in locally advanced breast cancer
|
Gomez, Henry L. | Pinto, Joseph A. | Olivera, Mivael | Vidaurre, Tatiana | Doimi, Franco D. | Vigil, Carlos E. | Velarde, Raul G. | Abugattas, Julio E. | Alarcon, Edith | Vallejos, Carlos S.
|
2011
|
10.1016/J.BREAST.2010.06.009
|
BREAST
|
|
Q1
|
|
Journal-article
|
Topoisomerase II-α as a predictive factor of response to therapy with anthracyclines in locally advanced breast cancer
|
|
2011
|
10.1016/J.BREAST.2010.06.009
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
BIM Expression in Treatment-Naive Cancers Predicts Responsiveness to Kinase Inhibitors
|
Faber, Anthony C. | Corcoran, Ryan B. | Ebi, Hiromichi | Sequist, Lecia V. | Waltman, Belinda A. | Chung, Euiheon | Incio, Joao | Digumarthy, Subba R. | Pollack, Sarah F. | Song, Youngchul | Muzikansky, Alona | Lifshits, Eugene | Roberge, Sylvie | Coffman, Erik J. | Benes, Cyril H. | Gomez, Henry L. | Baselga, Jose | Arteaga, Carlos L. | Rivera, Miguel N. | Dias-Santagata, Dora | Jain, Rakesh K. | Engelman, Jeffrey A.
|
2011
|
10.1158/2159-8290.CD-11-0106
|
Cancer Discovery
|
|
Q4
|
|
Journal-article
|
BIM expression in treatment-naïve cancers predicts responsiveness to kinase inhibitors
|
|
2011
|
10.1158/2159-8290.CD-11-0106
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
BIM expression in treatment-naïve cancers predicts responsiveness to kinase inhibitors
|
Faber A.
|
2011
|
10.1158/2159-8290.CD-11-0106
|
Cancer Discovery
|
|
2011: No disponible**, 2020: Q1
|
|
Artículo en revista científica
|
A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
|
Hamid O.
|
2011
|
10.1186/1479-5876-9-204
|
Journal of Translational Medicine
|
|
Q1
|
|
Journal-article
|
A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
|
|
2011
|
10.1186/1479-5876-9-204
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
|
Hamid, Omid | Schmidt, Henrik | Nissan, Aviram | Ridolfi, Laura | Aamdal, Steinar | Hansson, Johan | Guida, Michele | Hyams, David M. | Gomez, Henry | Bastholt, Lars | Chasalow, Scott D. | Berman, David
|
2011
|
10.1186/1479-5876-9-204
|
Journal of Translational Medicine
|
|
Q2
|
|
Journal-article
|
First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: Final results of an international phase II trial
|
|
2011
|
10.1200/JCO.2010.31.4187
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: Final results of an international phase II trial
|
Vitolo U.
|
2011
|
10.1200/JCO.2010.31.4187
|
Journal of Clinical Oncology
|
|
Q1
|
|
Journal - Article
|
First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial
|
Vitolo, Umberto | Chiappella, Annalisa | Ferreri, Andres J. M. | Martelli, Maurizio | Baldi, Ileana | Balzarotti, Monica | Bottelli, Chiara | Conconi, Annarita | Gomez, Henry | Lopez-Guillermo, Armando | Martinelli, Giovanni | Merli, Francesco | Novero, Domenico | Orsucci, Lorella | Pavone, Vincenzo | Ricardi, Umberto | Storti, Sergio | Gospodarowicz, Mary K. | Cavalli, Franco | Sarris, Andreas H. | Zucca, Emanuele
|
2011
|
10.1200/JCO.2010.31.4187
|
JOURNAL OF CLINICAL ONCOLOGY
|
|
Q1
|
|
Review
|
Implication of miRNA in the diagnosis and treatment of breast cancer
|
Castañeda C.
|
2011
|
10.1586/era.11.40
|
Expert Review of Anticancer Therapy
|
|
Q1
|
|
Journal-article
|
Implication of miRNA in the diagnosis and treatment of breast cancer
|
|
2011
|
10.1586/ERA.11.40
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Review
|
Implication of miRNA in the diagnosis and treatment of breast cancer
|
Castaneda, Carlos A. | Teresa Agullo-Ortuno, Maria | Fresno Vara, Juan Angel | Cortes-Funes, Hernan | Gomez, Henry L. | Ciruelos, Eva
|
2011
|
10.1586/ERA.11.40
|
Expert Review of Anticancer Therapy
|
|
Q2
|
|
Artículo en revista científica
|
Global experience with ixabepilone in breast cancer
|
Kaklamani V.G.
|
2011
|
10.1586/era.11.41
|
Expert Review of Anticancer Therapy
|
|
Q1
|
|
Journal - Review
|
Global experience with ixabepilone in breast cancer
|
Kaklamani, Virginia G. | Xu, Binge H. | Gomez, Henry L.
|
2011
|
10.1586/ERA.11.41
|
Expert Review of Anticancer Therapy
|
|
Q2
|
|
Journal-article
|
Global experience with ixabepilone in breast cancer
|
|
2011
|
10.1586/ERA.11.41
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes
|
Hortobagyi G.N.
|
2010
|
10.1007/s10549-010-0901-4
|
Breast Cancer Research and Treatment
|
|
Q1
|
|
Journal-article
|
Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes
|
|
2010
|
10.1007/S10549-010-0901-4
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes
|
Hortobagyi, Gabriel N. | Gomez, Henry L. | Li, Rubi K. | Chung, Hyun-Cheol | Fein, Luis E. | Chan, Valorie F. | Jassem, Jacek | Lerzo, Guillermo L. | Pivot, Xavier B. | Hurtado de Mendoza, Fernando | Xu, Binghe | Vahdat, Linda T. | Peck, Ronald A. | Mukhopadhyay, Pralay | Roche, Henri H.
|
2010
|
10.1007/S10549-010-0901-4
|
BREAST CANCER RESEARCH AND TREATMENT
|
|
Q1
|
|
Review
|
The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer
|
Castaneda C.
|
2010
|
10.1007/s10555-010-9261-0
|
Cancer and Metastasis Reviews
|
|
Q1
|
|
Journal - Review
|
The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer
|
Castaneda, Carlos A. | Cortes-Funes, Hernan | Gomez, Henry L. | Ciruelos, Eva M.
|
2010
|
10.1007/S10555-010-9261-0
|
CANCER AND METASTASIS REVIEWS
|
|
Q1
|
|
Journal-article
|
The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer
|
|
2010
|
10.1007/S10555-010-9261-0
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal-article
|
Clinical benefit of lapatinib-based therapy in patients with human epidermal growth factor receptor 2-positive breast tumors coexpressing the truncated p95HER2 receptor
|
|
2010
|
10.1158/1078-0432.CCR-09-3407
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Clinical benefit of lapatinib-based therapy in patients with human epidermal growth factor receptor 2-positive breast tumors coexpressing the truncated p95HER2 receptor
|
Scaltriti M.
|
2010
|
10.1158/1078-0432.CCR-09-3407
|
Clinical Cancer Research
|
|
Q1
|
|
Journal - Article
|
Clinical Benefit of Lapatinib-Based Therapy in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Tumors Coexpressing the Truncated p95HER2 Receptor
|
Scaltriti, Maurizio | Chandarlapaty, Sarat | Prudkin, Ludmila | Aura, Claudia | Jimenez, Jose | Davide Angelini, Pier | Sanchez, Gertrudis | Guzman, Marta | Lluis Parra, Josep | Ellis, Catherine | Gagnon, Robert | Koehler, Maria | Gomez, Henry | Geyer, Charles | Cameron, David | Arribas, Joaquin | Rosen, Neal | Baselga, Jose
|
2010
|
10.1158/1078-0432.CCR-09-3407
|
CLINICAL CANCER RESEARCH
|
|
Q1
|
|
Journal-article
|
Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer
|
|
2010
|
10.1158/1078-0432.CCR-10-1265
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer
|
Tabchy A.
|
2010
|
10.1158/1078-0432.CCR-10-1265
|
Clinical Cancer Research
|
|
Q1
|
|
Journal - Article
|
Evaluation of a 30-Gene Paclitaxel, Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy Response Predictor in a Multicenter Randomized Trial in Breast Cancer
|
Tabchy, Adel | Valero, Vicente | Vidaurre, Tatiana | Lluch, Ana | Gomez, Henry | Martin, Miguel | Qi, Yuan | Javier Barajas-Figueroa, Luis | Souchon, Eduardo | Coutant, Charles | Doimi, Franco D. | Ibrahim, Nuhad K. | Gong, Yun | Hortobagyi, Gabriel N. | Hess, Kenneth R. | Symmans, W. Fraser | Pusztai, Lajos
|
2010
|
10.1158/1078-0432.CCR-10-1265
|
CLINICAL CANCER RESEARCH
|
|
Q1
|
|
Journal-article
|
Quality-of-life and quality-adjusted survival (Q-TWiST) in patients receiving lapatinib in combination with paclitaxel as first-line treatment for metastatic breast cancer
|
|
2010
|
10.1185/03007991003590860
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
Quality-of-life and quality-adjusted survival (Q-TWiST) in patients receiving lapatinib in combination with paclitaxel as first-line treatment for metastatic breast cancer
|
Sherrill, Beth | Di Leo, Angelo | Amonkar, Mayur M. | Wu, Yun | Zvirbule, Zanete | Aziz, Zeba | Bines, Jose | Gomez, Henry L.
|
2010
|
10.1185/03007991003590860
|
CURRENT MEDICAL RESEARCH AND OPINION
|
|
Q1
|
|
Artículo en revista científica
|
Quality-of-life and quality-adjusted survival (Q-TWiST) in patients receiving lapatinib in combination with paclitaxel as first-line treatment for metastatic breast cancer
|
Sherrill B.
|
2010
|
10.1185/03007991003590860
|
Current Medical Research and Opinion
|
|
Q1
|
|
Review
|
Chemotherapy resistance in metastatic breast cancer: The evolving role of ixabepilone
|
Rivera E.
|
2010
|
10.1186/bcr2573
|
Breast Cancer Research
|
|
Q1
|
|
Journal - Article
|
Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone
|
Rivera, Edgardo | Gomez, Henry
|
2010
|
10.1186/BCR2573
|
|
|
S/C***
|
|
Journal-article
|
Chemotherapy resistance in metastatic breast cancer: The evolving role of ixabepilone
|
|
2010
|
10.1186/BCR2731
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Erratum
|
Erratum: The publisher would like to apologize on behalf of the authors. Since publication of the ORIGINAL ARTICLE: CLINICAL (Leukemia and Lymphoma (2009) 50(6) 925-931
|
Martinelli G.
|
2010
|
10.3109/10428191003630246
|
Leukemia and Lymphoma
|
|
No Aplica
|
|
Journal-article
|
Erratum: The publisher would like to apologize on behalf of the authors. Since publication of the ORIGINAL ARTICLE: CLINICAL (Leukemia and Lymphoma (2009) 50(6) 925-931
|
|
2010
|
10.3109/10428191003630246
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Breast cancer classification according to immunohistochemistry markers: Subtypes and association with clinicopathologic variables in a peruvian hospital database
|
Vallejos C.
|
2010
|
10.3816/CBC.2010.n.038
|
Clinical Breast Cancer
|
|
Q2
|
|
Journal-article
|
Breast cancer classification according to immunohistochemistry markers: Subtypes and association with clinicopathologic variables in a peruvian hospital database
|
|
2010
|
10.3816/CBC.2010.N.038
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal - Article
|
Breast Cancer Classification According to Immunohistochemistry Markers: Subtypes and Association With Clinicopathologic Variables in a Peruvian Hospital Database
|
Vallejos, Carlos S. | Gomez, Henry L. | Cruz, Wilder R. | Pinto, Joseph A. | Dyer, Richard R. | Velarde, Raul | Suazo, Juan F. | Neciosup, Silvia P. | Leon, Mauricio | de la Cruz, Miguel A. | Vigil, Carlos E.
|
2010
|
10.3816/CBC.2010.N.038
|
Clinical Breast Cancer
|
|
Q2
|
|
Journal-article
|
Prognostic effect of hormone receptor status in early HER2 positive breast cancer patients
|
|
2010
|
10.5144/1658-3876.2010.109
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Prognostic effect of hormone receptor status in early HER2 positive breast cancer patients
|
Gómez H.
|
2010
|
10.5144/1658-3876.2010.109
|
Hematology/ Oncology and Stem Cell Therapy
|
|
Q4
|
|
Artículo en revista científica
|
Analysis of dermatologic events in patients with cancer treated with lapatinib
|
Lacouture M.E.
|
2009
|
10.1007/S10549-008-0020-7
|
Breast Cancer Research and Treatment
|
|
Q1
|
|
Journal-article
|
Analysis of dermatologic events in patients with cancer treated with lapatinib
|
|
2009
|
10.1007/S10549-008-0020-7
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal-article
|
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
|
|
2009
|
10.1016/S0140-6736(09)61416-1
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
|
Ferreri A.J.
|
2009
|
10.1016/S0140-6736(09)61416-1
|
Lancet, The
|
|
Q1
|
|
Artículo en revista científica
|
Targeted therapies: Combined lapatinib and paclitaxel in HER2-positive breast cancer
|
Castañeda C.A.
|
2009
|
10.1038/NRCLINONC.2009.68
|
Nature Reviews Clinical Oncology
|
|
Q1
|
|
Journal-article
|
Targeted therapies: Combined lapatinib and paclitaxel in HER2-positive breast cancer
|
|
2009
|
10.1038/NRCLINONC.2009.68
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Early stage gastric diffuse large B-cell lymphomas: Results of a randomised trial comparing chemotherapy alone versus chemotherapy + involved field radiotherapy
|
Martinelli G.
|
2009
|
10.1080/10428190902912478
|
Leukemia and Lymphoma
|
|
Q2
|
|
Journal-article
|
Early stage gastric diffuse large B-cell lymphomas: Results of a randomised trial comparing chemotherapy alone versus chemotherapy + involved field radiotherapy
|
|
2009
|
10.1080/10428190902912478
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal-article
|
In reply
|
|
2009
|
10.1200/JCO.2008.20.0741
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Letter
|
In reply
|
Castañeda C.
|
2009
|
10.1200/JCO.2008.20.0741
|
Journal of Clinical Oncology
|
|
No Aplica
|
|
Artículo en revista científica
|
Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor - Positive metastatic breast cancer
|
Johnston S.
|
2009
|
10.1200/JCO.2009.23.3734
|
Journal of Clinical Oncology
|
|
Q1
|
|
Journal-article
|
Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor - Positive metastatic breast cancer
|
|
2009
|
10.1200/JCO.2009.23.3734
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal-article
|
Pazopanib: An antiangiogenic drug in perspective
|
|
2009
|
10.2217/FON.09.112
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Review
|
Pazopanib: An antiangiogenic drug in perspective
|
Castaneda C.A.
|
2009
|
10.2217/FON.09.112
|
Future Oncology
|
|
Q1
|
|
Journal-article
|
Erratum: Early stage gastric diffuse large B-cell lymphomas: Results of a randomised trial comparing chemotherapy alone versus chemotherapy + involved field radiotherapy (Leukemia and Lymphoma (2009) 50:6 (925-931))
|
|
2009
|
10.3109/10428190903396049
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Erratum
|
Erratum: Early stage gastric diffuse large B-cell lymphomas: Results of a randomised trial comparing chemotherapy alone versus chemotherapy + involved field radiotherapy (Leukemia and Lymphoma (2009) 50:6 (925-931))
|
Martinelli G.
|
2009
|
10.3109/10428190903396049
|
Leukemia and Lymphoma
|
|
No Aplica
|
|
Artículo en revista científica
|
Prolonged disease control in a patient with anthracycline- and taxane-resistant breast cancer
|
Castaneda C.
|
2009
|
10.3816/CBC.2009.N.046
|
Clinical Breast Cancer
|
|
Q2
|
|
Journal-article
|
Prolonged disease control in a patient with anthracycline- and taxane-resistant breast cancer
|
|
2009
|
10.3816/CBC.2009.N.046
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
PIK3CA-activating mutations and chemotherapy sensitivity in stage II-III breast cancer
|
Liedtke C.
|
2008
|
10.1186/BCR1984
|
Breast Cancer Research
|
|
Q1
|
|
Journal-article
|
PIK3CA-activating mutations and chemotherapy sensitivity in stage II-III breast cancer
|
|
2008
|
10.1186/BCR1984
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Treatment of advanced hormone-sensitive breast cancer in postmenopausal women with exemestane alone or in combination with celecoxib
|
Dirix L.
|
2008
|
10.1200/JCO.2007.13.3744
|
Journal of Clinical Oncology
|
|
Q1
|
|
Journal-article
|
Treatment of advanced hormone-sensitive breast cancer in postmenopausal women with exemestane alone or in combination with celecoxib
|
|
2008
|
10.1200/JCO.2007.13.3744
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancer
|
Gomez H.L.
|
2008
|
10.1200/JCO.2007.14.0590
|
Journal of Clinical Oncology
|
|
Q1
|
|
Journal-article
|
Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancer
|
|
2008
|
10.1200/JCO.2007.14.0590
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer
|
Di Leo A.
|
2008
|
10.1200/JCO.2008.16.2578
|
Journal of Clinical Oncology
|
|
Q1
|
|
Journal-article
|
Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer
|
|
2008
|
10.1200/JCO.2008.16.2578
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal-article
|
Case study: Lapatinib monotherapy as first-line treatment in metastatic breast cancer
|
|
2008
|
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal-article
|
Lapatinib monotherapy as first-line treatment in metastatic breast cancer
|
|
2008
|
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Note
|
Case study: Lapatinib monotherapy as first-line treatment in metastatic breast cancer
|
Castañeda C.
|
2008
|
|
American Journal of Hematology/ Oncology
|
|
No Aplica
|
|
Artículo en revista científica
|
Lapatinib monotherapy as first-line treatment in metastatic breast cancer
|
Castañeda C.A.
|
2008
|
|
American Journal of Hematology/ Oncology
|
|
Q4
|
|
Artículo en revista científica
|
Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study
|
Gong Y.
|
2007
|
10.1016/S1470-2045(07)70042-6
|
Lancet Oncology, The
|
|
Q1
|
|
Journal-article
|
Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study
|
|
2007
|
10.1016/S1470-2045(07)70042-6
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment
|
Thomas E.S.
|
2007
|
10.1200/JCO.2007.12.6557
|
Journal of Clinical Oncology
|
|
Q1
|
|
Journal-article
|
Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment
|
|
2007
|
10.1200/JCO.2007.12.6557
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
A phase II trial of pemetrexed in advanced breast cancer: Clinical response and association with molecular target expression
|
Gomez H.L.
|
2006
|
10.1158/1078-0432.CCR-05-0295
|
Clinical Cancer Research
|
|
Q1
|
|
Journal-article
|
A phase II trial of pemetrexed in advanced breast cancer: Clinical response and association with molecular target expression
|
|
2006
|
10.1158/1078-0432.CCR-05-0295
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer
|
Hess K.R.
|
2006
|
10.1200/JCO.2006.05.6861
|
Journal of Clinical Oncology
|
|
Q1
|
|
Journal-article
|
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer
|
|
2006
|
10.1200/JCO.2006.05.6861
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal-article
|
Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the international extranodal lymphoma study group
|
|
2003
|
10.1200/JCO.2003.11.141
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Review
|
Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the international extranodal lymphoma study group
|
Zucca E.
|
2003
|
10.1200/JCO.2003.11.141
|
Journal of Clinical Oncology
|
|
Q1
|
|
Journal-article
|
The modified International Prognostic Index can predict the outcome of localized primary intestinal lymphoma of both extranodal marginal zone B-cell and diffuse large B-cell histologies
|
|
2002
|
10.1046/J.1365-2141.2002.03613.X
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
The modified International Prognostic Index can predict the outcome of localized primary intestinal lymphoma of both extranodal marginal zone B-cell and diffuse large B-cell histologies
|
Cortelazzo S.
|
2002
|
10.1046/J.1365-2141.2002.03613.X
|
British Journal of Haematology
|
|
Q1
|
|
Journal-article
|
Relevance of intraocular involvement in the management of primary central nervous system lymphomas
|
|
2002
|
10.1093/ANNONC/MDF080
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Relevance of intraocular involvement in the management of primary central nervous system lymphomas
|
Ferreri A.J.M.
|
2002
|
10.1093/ANNONC/MDF080
|
Annals of Oncology
|
|
Q1
|
|
Artículo en revista científica
|
A multicenter study of treatment of primary CNS lymphoma
|
Ferreri A.J.M.
|
2002
|
10.1212/WNL.58.10.1513
|
Neurology
|
|
Q1
|
|
Journal-article
|
A multicenter study of treatment of primary CNS lymphoma
|
|
2002
|
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
A phase II study of neoadjuvant gemcitabine plus doxorubicin in stage IIIB breast cancer: A preliminary report
|
Gomez H.
|
2001
|
10.1016/S0093-7754(01)80010-5
|
Seminars in Oncology
|
|
Q1
|
|
Journal-article
|
A phase II study of neoadjuvant gemcitabine plus doxorubicin in stage IIIB breast cancer: A preliminary report
|
|
2001
|
10.1016/S0093-7754(01)80010-5
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal-article
|
A phase II study of a novel gemcitabine plus cisplatin regimen administered every three weeks for advanced non-small-cell lung cancer
|
|
1998
|
10.1023/A:1008276507236
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
A phase II study of a novel gemcitabine plus cisplatin regimen administered every three weeks for advanced non-small-cell lung cancer
|
Castellano D.
|
1998
|
10.1023/A:1008276507236
|
Annals of Oncology
|
|
1998: No disponible**, 1999: Q1
|
|
Artículo en revista científica
|
Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: Results of a multivariate analysis
|
Gómez H.
|
1998
|
10.1200/JCO.1998.16.6.2065
|
Journal of Clinical Oncology
|
|
1998: No disponible**, 1999: Q1
|
|
Artículo en revista científica
|
Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: Identification of two age subgroups with differing hematologic toxicity
|
Gómez H.
|
1998
|
10.1200/JCO.1998.16.7.2352
|
Journal of Clinical Oncology
|
|
1998: No disponible**, 1999: Q1
|
|
Journal-article
|
Elderly patients with aggressive non-Hodgkins lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: Identification of two age subgroups with differing hematologic toxicity
|
|
1998
|
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal-article
|
Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkins lymphoma: Results of a multivariate analysis
|
|
1998
|
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Journal-article
|
Treatment of lymphoma in the elderly | Tratamiento del linfoma en el anciano
|
|
1998
|
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Editorial
|
Treatment of lymphoma in the elderly
|
Gomez H.
|
1998
|
|
Medicina Clinica
|
|
No Aplica
|
|
Artículo en revista científica
|
Ifosfamide plus cisplatin as primary chemotherapy of advanced ovarian cancer
|
Vallejos C.
|
1997
|
10.1006/GYNO.1997.4845
|
Gynecologic Oncology
|
|
1997: No disponible**, 1999: Q1
|
|
Journal-article
|
Ifosfamide plus cisplatin as primary chemotherapy of advanced ovarian cancer
|
|
1997
|
10.1006/GYNO.1997.4845
|
|
Scopus - Elsevier a través de ORCID
|
|
|
Artículo en revista científica
|
Patient selection in high-dose chemotherapy trials: Relevance in high- risk breast cancer
|
García-Carbonero R.
|
1997
|
10.1200/JCO.1997.15.10.3178
|
Journal of Clinical Oncology
|
|
1997: No disponible**, 1999: Q1
|
|
Journal-article
|
Patient selection in high-dose chemotherapy trials: Relevance in high- risk breast cancer
|
|
1997
|
|
|
Scopus - Elsevier a través de ORCID
|
|